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Abstract 
Astrocytes are emerging as important regulators of neural circuit function and 
behavior in the healthy and diseased nervous system. In a screen for astrocyte 
molecules that modulate neuronal hyperexcitability we identified multiple 
components of focal adhesion complexes (FAs) as potent suppressors of 
genetically- or pharmacologically-induced seizure-like activity. Depletion of 
astrocytic Tensin, β-integrin, Talin, Focal adhesion kinase (FAK), or matrix 
metalloproteinase 1 (Mmp1), which degrades extracellular matrix to activate β-
integrin receptors, resulted in enhanced recovery from, or resistance to seizure 
activity. Reciprocally, promoting FA signaling by overexpression of Mmp1 in 
astrocytes led to enhanced-seizure severity. Blockade of FA signaling in 
astrocytes led to reduced-astrocytic coverage of the synaptic neuropil and 
reduced expression of the excitatory amino acid transporter EAAT1. However, 
upon seizure induction, depletion of FA signaling components resulted in 
enhanced astrocyte coverage of the synaptic neuropil and a ~2-fold increase in 
EAAT1 levels compared to controls. Our data indicate that FAs promote 
astrocyte coverage in neuropil and EAAT1 expression under normal 
physiological conditions, but in the context of hyperexcitability, FAs negatively 
regulate the extent of astrocytic processes within neuropil and EAAT1 expression, 
thereby inhibiting a more rapid recovery from conditions of excessive neuronal 
activity. 
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Chapter 1: Introduction 
The nervous system requires intricate connections between cells and the 
constant communication between them governs network activity and function of 
the brain. Neurons are one of the main residents in the nervous system and they 
are connected to one other through synapses. Transmitting electrical signals is a 
unique property of neurons and understanding how signals from different 
neurons work together to generate circuit output has been a great interest in our 
efforts to understand the cellular and molecular basis of information processing in 
the brain.  
 The two main types of neurons are excitatory and inhibitory, whose firing 
rates help establish the excitatory and inhibitory (E/I) balance in the brain.  The 
maintenance of a balanced (E/I) state in neuronal networks throughout the 
lifetime of an organism is essential: deregulation of the E/I balance is associated 
with a variety of disorders including epilepsy, autism, schizophrenia, and 
Alzheimer’s disease (Belforte et al., 2009; Heinemann, 2004; Rubenstein, 2010; 
Yizhar et al., 2011). 
However, understanding neuronal contributions to E/I balance is only part 
of the puzzle.  Glia, another resident brain cell type, adds a new dimension to the 
regulation of brain physiology, including E/I balance.  Glial cells, which take up 
more than half of the volume of the human brain (Eroglu and Barres, 2010), used 
to be thought of as “Nervenkitt” (the German word for nerve glue) (Jäkel and 
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Dimou, 2017).  Unlike the name suggests, they are now known to be 
indispensible for the structural and functional development as well as 
maintenance of a healthy state of the nervous system (Freeman et al., 2003; 
Zuchero and Barres, 2015).  An explosion of research on glial function in the 
nervous system over the past decade has greatly enlightened us about the 
importance of glial cell functions in the orchestration of proper neuronal network 
activity.   
 There are different primary subtypes of glia in the mammalian brain, and 
each has their own unique properties.  Oligodendrocytes and Schwann cells are 
myelinating glia that electrically insulate axons to control conduction velocity and 
provide trophic support for the axons.  Thus they regulate how fast and/or 
efficient neuronal signal transmission occurs over long distances in the nervous 
system.  Microglia, the resident immune cells in the CNS function as regulators of 
activity-dependent pruning of neuronal synapses on top of their traditional roles 
regarding immune responses during inflammation and diseases (Schafer and 
Stevens, 2015; Stevens et al., 2007).  Finally, astrocytes, also known as a third 
component of synapses (to compose tripartite synapse), have tight coupling with 
neuronal synapses and they execute a wide range of functions to sculpt neuronal 
network activity (Chung et al., 2015; Halassa and Haydon, 2010).  The precise 
roles that astrocytes play in regulating neuronal activity are not clear.  Astrocyte 
membranes are filled with ion channels, receptors, and transporters for 
neurotransmitters, suggesting diverse mechanisms for circuit modulation, but 
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functions for very few of these astrocytic molecules have been defined in vivo.  
Considering this intimate structural and functional relationship between 
astrocytes and neuronal synapses, it is not surprising that astrocytes have a 
strong presence in neural circuit function and behavior.  Below I provide a brief 
overview of the mechanisms by which astrocytes regulate neuronal activity and 
synaptic function, and other aspects of brain physiology.  
 
Astrocyte regulation of neuronal metabolism, connectivity and 
function 
 
The blood-brain barrier (BBB) 
Exchange of ions and molecules between the brain and the blood vessels is 
tightly regulated by the blood-brain barrier (BBB).  This physical barrier is critical 
for proper neuronal function allowing the brain maintain the ionic homeostasis, 
supply nutrients, and keep out toxins and pathogens (Daneman and Prat, 2015).  
Three cell types compose the BBB including endothelial cells, pericytes, and 
astrocytes.  Astrocytes form cellular extensions, called endfeet, that make 
contact with and together coat almost the entire outer surface of the vasculature 
through the dystroglycan-dystrophin complex (Noell et al., 2011).  This point of 
contact is thought to be the site of exchange of materials between astrocytes and 
the vasculature, which allows the remainder of the astrocyte tree of cellular 
processes to exchange materials with neurons.  Studies from brain acute slices 
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and isolated retina provide strong evidence that astrocytes can regulate blood 
flow in response to neuronal activity through prostaglandins and 
epoxyeicosatrienoic acids, which can dilate blood vessels (Metea, 2006; Zonta et 
al., 2002).  The obvious implication is that increased activity requires increased 
energy, with vasodilation increasing rates of exchange.  While there is 
controversy over astrocyte roles in the initial formation of the BBB, it is clear that 
astrocytes perform critical roles in BBB functions such as regulating the blood 
flux and maintaining proper barrier for the homeostasis.  Implications of BBB 
dysfunction during pathological conditions and diseases like cerebral ischemia, 
brain trauma, glioblastoma, stroke, multiple sclerosis, epilepsy, Alzheimer and 
Parkinson’s diseases highlight astrocytes as a key component of this barrier to 
maintain a healthy and functional brain (Barreto, 2014).  
 
Metabolic support 
Astrocytes are ubiquitous in the nervous system and associate with nearly all 
types of neurons, at the same time they are tightly associated with the 
vasculature, and astrocytes form extensive gap junctions with each other, 
thereby allowing rapid exchange of ions and metabolic intermediates throughout 
the astrocyte population and, in turn, the brain.  One of the first roles of 
astrocytes that was recognized is their capability for maintaining energy 
homeostasis in the brain, and this ability depends heavily on their morphology. 
The brain only represents 2% of the human body mass, but it utilizes about 20% 
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of the oxygen and glucose in our systems.  Neurons are believed to receive their 
energy supplies through the lactate shuttle, a key proposed operational model to 
keep up with such a high-energy requirement in the nervous system (Magistretti, 
2006). Briefly, the endfeet of astrocytes, which line cerebral microvessels, take 
up glucose through astrocyte-specific transporters. Glucose taken up by 
astrocytes is then stored in the form of glycogen via glycogenesis or shuttled 
back to the neurons as lactic acid after glycolysis (Tsacopoulos and Magistretti, 
1996).  Astrocytes aid in this diffusion of glucose due to their extensive coupling 
through gap junctions.  Gap junctions are specialized intercellular conduits that 
allow the diffusion of glucose (and ions) to neighboring astrocytes. Genetic 
ablation studies shows connexins, gap junction proteins in astrocytes are 
required for activity-dependent changes in synaptic transmission and neuronal 
metabolism (Rouach et al., 2008).  Because of the highly networked properties of 
astrocytes in the brain, glucose taken up by a few astrocytes can rapidly diffuse 
throughout the brain (Kacem et al., 1998; Signaling at the Gliovascular Interface, 
2003; Theis et al., 2005), and thus allow the brain to keep up with metabolic 
demand in neurons.   
 Although glucose metabolism has been studied most extensively, it is 
believed that astrocyte networks function in similar ways throughout the brain to 
drive the central/peripheral exchange of additional bioenergetics intermediates, 
metabolic byproducts, and gases (O2/CO2).  The extent of exchange remains 
unclear, but astrocytes membranes are equipped with a range of transporters 
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and channels (Minelli et al., 1996; Rothstein et al., 1994; Seifert et al., 2016; 
Theis et al., 2005), suggesting a broad array of substrates can be mobilized to 
and from neurons. 
 
Ion and pH balance 
In the nervous system, changes in pH are caused by neuronal activity and 
directly modulate neuronal excitability and synaptic transmission by affecting the 
release of neurotransmitters, conductance of voltage-gated channels and ligand-
gated channels, K+ and Ca2+ channels, proton gated channels as well as 
glutamate receptors (Obara et al., 2008).  While there are multiple barrier 
mechanisms to keep the proper pH balance in the brain, astrocytes serve a key 
role, as they are equipped with several molecules by which they can regulate pH.  
For instance, astrocytes membranes are decorated with the Na+/H+ exchanger, 
bicarbonate transporters, monocarboxylic acid transporters, and the vacuolar-
type proton ATPase, all of which are directly involved in transporting H+ ions 
(Sofroniew and Vinters, 2009).  The presence of these mechanisms for H+ 
regulation render astrocytes sensitive to pH fluctuations, and provide a means for 
astrocytic regulation of extracellular pH (Chesler, 2003).   
 
Astrocyte control of synapse formation and maturation 
The synapse is the basic functional unit for communication in the brain and there 
is significant interest in understanding how synapses form and exhibit plasticity.  
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Over the past decade, significant evidence has been mounting that demonstrates 
a central role for astrocytes in nearly every aspect of synapse formation and 
physiology.   
Synapse formations are the initial stage of their development and there is 
strong evidence from various studies to show astrocytes are required for this 
process.  Elegant studies from the Barres laboratory first revealed that astrocyte-
secreted factors are potent modulators of synapse formation.  Using an in vitro 
culture system Barres and colleagues attempted to identify factors in astrocyte-
conditioned medium that would enhance synapse formation or efficacy, and this 
was extremely successful (Buard et al., 2009; Diniz et al., 2012; Hughes et al., 
2010; Pfrieger and Barres, 1997; Ullian et al., 2004; Xu et al., 2009).  
 Thrombospondins (TSPs) are secreted by astrocytes to control synapse 
formation, and their expression in astrocytes is observed in vivo (Christopherson 
et al., 2005).  In particular, TSP1 and TSP2 expression coincide with the timing of 
synaptogenesis and genetic depletion of both TSP1 and TSP2 show impairment 
of synapse formation in the mouse.  TSPs exert their pro-synaptogenic effects 
through binding and activation of α2δ receptors that are expressed in neurons 
(Eroglu et al., 2009).  Additional factors secreted from astrocytes that control 
synapse number are hevin and SPARC.  While hevin can promote 
synaptogenesis, SPARC negatively regulates synapse formation by antagonizing 
the function of hevin (Kucukdereli et al., 2011).  In addition to secreted factors , 
contact-dependent regulation of synapse formation by astrocytes has also been 
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proposed (Hama et al., 2004).  This contact-mediated signaling activates 
neuronal integrin receptors resulting in the activation of protein kinase C 
signaling pathway in hippocampal neurons (Hama et al., 2004), and developing 
retina ganglion cells are suggested to utilize different contact-mediated signals to 
promote synapse formation (Barker et al., 2008).  It appears that the regulation of 
synaptogenesis by astrocytes is conserved in invertebrates as recent genetic 
ablation studies in Drosophila melanogaster provide direct evidence of astrocytic 
involvement of synapse formation during the development of fly brain 
(Muthukumar et al., 2014). 
 Synapse formation occurs through the stepwise process of assembly of 
structural synapses (i.e. silent synapses), followed by activation of signaling 
properties.  TSPs are sufficient to induce the formation of silent synapses, but not 
functionally active ones (Xu et al., 2009).  In a subsequent analysis of pro-
synaptogenic factors in astrocyte-conditioned medium, Allen and colleagues 
discovered a number of molecules capable of inducing fully mature synapses.  
Using a similar in vitro biochemical approach they identified glypicans, a family of 
heparin sulphate proteoglycans as necessary and sufficient for synapse 
maturation (Allen et al., 2012).  Glypicans are tethered to the cell plasma 
membrane by glycosyl-phosphatidylinositol linkages and endogenous 
phospholipases can cleave to release the proteins (Clarke and Barres, 2013).  
Mouse astrocytes express glypican 4 and 6 in vivo and mice with glypican 4 
depletion have a defects in synapse formation, and function: the amplitude of 
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excitatory postsynaptic currents is dramatically decreased with an impaired 
recruitment of AMPA receptors (Allen et al., 2012).  The glypicans are well-
conserved molecules throughout different species.  Drosophila melanogaster has 
a homologue of glypican 4 called Dally-like which binds to the protein tyrosine 
phosphatase receptor leukocyte antigen-related receptor (LAR) in neurons to 
regulate the maturation of synapses (Johnson et al., 2006).  Another study in 
mammalian hippocampal neurons also suggests LAR signaling is required for 
recruitment of AMPA receptors to synapses (Dunah et al., 2005).  With these 
interesting insights, further studies will provide underlying mechanisms of how 
astrocyte glypicans act on neuronal receptors to induce synapse maturation.  
 Maintenance of proper synapse number requires removal of excess 
synaptic connections during nervous system development (Kano and Hashimoto, 
2009) and the failure of synapse eliminations alters synaptic connectivity and is 
associated with devastating neurological disorders including autism and 
schizophrenia (Boksa, 2012; Zoghbi and Bear, 2012).  Mounting evidence shows 
microglia, the resident immune cells in the brain, are major players in synapse 
elimination and pruning in the mouse retinogeniculate system (Schafer et al., 
2012).  Briefly, microglia express the complement receptor CR3, through which 
they recognize and phagocytose C1q-tagged weaker “loser” synapses (Schafer 
et al., 2012).  At the same time, astrocytes also help prune synapses in the 
retinogeniculate system: astrocytes express MEGF10 (mouse Draper) and 
MERTK, and these receptors act in a partially redundant fashion to engulf 
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synapses destined for elimination (Chung et al., 2014).  Interestingly, C1q has 
recently been proposed to be the ligand for MEGF10 (Iram et al., 2016), which 
might explain how CR3-bearing microglia and MEGF10/MERTK-bearing 
astrocytes recognize common synaptic targets.  Drosophila astrocytes also 
efficiently phagocytose pruned synapses during neuronal remodeling (Hakim et 
al., 2014; Tasdemir-Yilmaz and Freeman, 2014), and this is where the Draper 
signaling cascade was first implicated in synaptic pruning (Awasaki et al., 2006).  
Interestingly, Mcr, the sole compmlement-like molecule in Drosophila appears to 
act genetically upstream of and potentially as a ligand for Draper in the activation 
of autophagy (Lin et al., 2017), and therefore Mcr/C1q tagging of engulfment 
targets for internalization by Draper/MEGF10 may be an additional conserved 
feature in phagocytic functions in the brain.   
 
Astrocyte regulation of neuronal activity  
Synaptic signaling to astrocytes 
Do astrocytes receive signaling information from synapses?  This is a central 
question in the field but has remained quite controversial.  Astrocytes express 
numerous receptors for neurotransmitters and stimulation of astrocytes with 
neurotransmitters trigger increases in intracellular second messengers such as 
calcium and cyclic AMP (Fiacco and McCarthy, 2006).  Calcium transients in 
astrocytes in response to neuronal activity were initially thought to be too slow to 
be regulating fast synaptic transmission and it seemed that only sustained and 
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intense neuronal activity could increase astrocyte calcium signaling (Perea, 
2005; Wang et al., 2006).  This slower response appears to act on a time scale 
more consistent with neuromodulation (seconds to minutes), and indeed recent 
studies have shown that astrocytic calcium signaling in Drosophila and mouse 
can be activated by octopamine/tyramine and norepinephrine, respectively (Ding 
et al., 2013; Duffy and MacVicar, 1995; Ma et al., 2016; Paukert et al., 2014; 
Salm and McCarthy, 1990).  In the Drosophila CNS, astrocytes have been shown 
to express the receptor for Oct/Tyr-R, activate calcium signaling in response to 
Oct/Tyr application, and be required for execution of neuromodulation in a 
dopaminergic circuit at both the electrophysiological and behavioral levels (Ma et 
al., 2016). 
 The role of faster time course microdomain calcium imaging events are 
less clear, although they are mediated by calcium release from mitochondria in 
some way (Agarwal et al., 2017).  Some evidence exists for their regulation by 
activity: two-photon imaging allowed for observation of astrocyte calcium 
transients that occur on a similar timescale to synaptic activity upon single-
synapse stimulation.  This type of astrocyte activation involves metabotropic 
glutamate subtype 5 receptors (Clarke and Barres, 2013; Panatier et al., 2011), 
but its physiological relevance remains unclear.  Finally, astrocytes have also 
been reported to detect the inhibitory neurotransmitter γ-aminobutyric acid 
(GABA) via metabotropic GABA receptor (GABABR1/2), with signaling through 
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this pathway modulate GABA transporter (GAT) expression and therefore GABA 
uptake rates in neural circuits (Muthukumar et al., 2014).  
Gliotransmitters 
One of the qualities that enable astrocytes to be active participants in the neural 
circuit behavior is their ability to release chemical transmitters called 
gliotransmitters.  Neurotransmitters released from presynaptic terminals can 
activate astrocytes to release various gliotransmitters including glutamate, D-
serine, ATP, and neuropeptide Y (Henneberger et al., 2010; Jourdain et al., 
2007; Mothet et al., 2005; Parpura et al., 1994; Pascual et al., 2005b; Schwarz et 
al., 2017), although in vivo evidence for release of any of these compounds is 
scarce.  Several studies suggest astrocytes release glutamate in a Ca2+-
dependent manner that is mediated by the soluble N-ethylmaleimide-sensitive 
factor attachment protein receptor (SNARE) proteins including vesicle-associated 
membrane proteins-2 (VAMP2), syntaxin-1, synaptosome-associated protein-23, 
and synaptobrevin II (Harada et al., 2016; Montana et al., 2006; Schwarz et al., 
2017).  While other release mechanisms, including reverse operation of plasma 
membrane glutamate transporters, cell swelling-induced anion transporter 
opening, release via P2X7 receptors, and gap junction-mediated extrusion have 
been reported (Harada et al., 2016).  D-serine in astrocytes has been proposed 
to be stored in the synaptic-like vesicles and released also in a Ca2+-dependent 
manner (Martineau et al., 2013).  Perhaps the best characterized potential 
gliotransmitter is ATP.  While the ATP release mechanisms still remain 
 13 
controversial, several studies suggested a gap junction channel, connexin 43 
(Torres et al., 2012) and secretory lysosomes (Verderio et al., 2012) as potential 
release mechanisms for ATP in astrocytes. 
 
Neurotransmitter clearance 
The major excitatory and inhibitory neurotransmitters in the mammalian brain are 
glutamate and GABA, respectively.  Their concentrations at synapses determine 
the extent of postsynaptic receptor activation.  Maintaining an appropriate 
extracellular concentration of these neurotransmitters is critical to maintain a high 
signal to noise ratio in synaptic and extrasynaptic modes of neurotransmission 
(Danbolt, 2001; Danbolt, 2013).  Cellular uptake is the only known mechanism by 
which cells can maintain Glu or GABA concentrations in the extracellular space, 
and there is thought to be no extracellular breakdown of either GABA or 
glutamate in the CNS.  Astrocytes express transporters for both Glu and GABA, 
and are the primary cell type in the brain that clears them from the extracellular 
space (Iversen and Johnston, 1971; Iversen and Kelly, 1975; Logan and Snyder, 
1971).  
 Glutamate uptake by glutamate transporters (Excitatory amino acid 
transporters, EAATs) is driven by the ion gradients of K+ and Na+ and the uptake 
of GABA by its transporters (GATs) is driven by the gradients of Na+ and Cl-.  
There are five high-affinity glutamate transporters in mammals, EAAT1 through 5 
and they belong to the slc1-family.  EAAT2 also known as GLT-1 was the first 
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one to be purified and characterized and it immediately became clear that they 
are highly expressed in astrocytes (Chaudhry et al., 1995; Danbolt et al., 2002).  
Both transporter activity blockade and knockout studies show that EAAT2 is 
responsible for 95 % of the total glutamate uptake activity (Danbolt et al., 1992; 
Tanaka et al., 1997).  EAAT2 knockout animals further implicated EAAT2 in 
preventing excitotoxicity, without its action, increased glutamate levels induce 
epilepsy and cell death (Tanaka et al., 1997).  Furthermore, depletion of EAAT1 
and EAAT2 in mice perturbed overall brain development including stem cell 
proliferation, radial migration of neurons, neuronal differentiation, and neuronal 
survival, presumably because of the buildup in extracellular glutamate 
(Matsugami et al., 2006).  These studies clearly suggest critical roles of astrocyte 
glutamate transporters in normal network activity, which directly correlates with 
brain development and health. 
 The first identified neurotransmitter transporter was the GABA transporter 
in mammals: GAT1, (slc6a1), and this was followed by the identification of 
another three members of the GABA transporters family (GAT2, GAT3, and 
BGT1) (Danbolt, 2013; Liu et al., 1993; López-Corcuera et al., 1992).  GAT3 is 
selectively expressed in astrocytes throughout the brain while GAT1 expression 
is both astrocytic and neuronal (Conti, 2014; Minelli et al., 1996; Ribak et al., 
1996; Yadav et al., 2015).  GAT1 deletion leads to reduced aggression, 
hypoalgesia, reduced anxiety, and depression-like behavior possibly because of 
increased extracellular GABA levels and enhanced inhibitory signaling (Danbolt, 
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2013).  While remaining astrocytic expression of GAT3 might complicate the 
interpretation of the above studies, recent studies in Drosophila melanogaster 
highlight critical roles of astrocytic GABA transporters in the function of the 
nervous system in vivo.  Gat encodes the sole slc6-family GABA transporter 
family member in Drosophila (Neckameyer and Cooper, 1998; Thimgan et al., 
2006) and its expression is exclusively astrocytic throughout development (Stork 
et al., 2014).  Flies with Gat deletion are embryonic lethal, but re-expression of 
Gat in astrocytes rescues these animals to adulthood.  Further support for the 
notion that balancing levels of GAT are critical for neurophysiology come from 
studies of GAT expression during development.  During Drosophila 
metamorphosis Gat expression in astrocytes is activated through GABABR1/2 
signaling pathway.  Decreases in GABABR1/2 signaling led to reduced astrocytic 
Gat expression resulting in suppression of seizure-like behavior.  These 
observations imply that GABA transporters play a central role in regulation of 
excitatory/inhibitory balance in the fly nervous system (Muthukumar et al., 2014). 
 
Astrocyte morphology 
Astrocyte’ fine processes are intimately associated with synapses. Ultrastructural 
studies in mammalian hippocampus showed about 60 % of synapses are in 
contact with astrocyte processes (Ventura and Harris, 1999).  Just like neuronal 
synapses, astrocyte processes undergo rapid morphological remodeling.  One of 
the striking observations supporting important roles for dynamic changes in 
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astrocyte processes comes from the studies of the hypothalamic supraoptic 
nucleus (SON)(Oliet et al., 2001).  In this study, researchers take advantage of 
the massive neurological remodeling that occurs in this system in response to 
specific physiological stimulations like lactation and dehydration.  Under these 
conditions, most of the astrocyte processes are moved away from synapses 
allowing enhanced synaptic communications.  Astrocytes resume their close 
association with synapses once the stimulation has been removed (Montagnese 
et al., 1990; Theodosis, 2002).  This structural plasticity in astrocytes upon 
synaptic remodeling changes the proximity between astrocytes and neighboring 
synapses to bring alterations in circuit behavior (Benediktsson et al., 2005; 
Haber, 2006; Hirrlinger et al., 2004).  Furthermore the correlation between 
dendritic spine stability and astrocyte contacts suggests important roles in 
astrocyte process motility and synapse maintenance (Haber, 2006).  
Regulation of astrocytes’ fine processes in association with synapse proximity 
also has a great impact on buffering of the glutamate released at the synapse.  
Astrocyte glutamate transporters expressed in their fine processes are the major 
mechanism for clearance of glutamate during synaptic transmission (Danbolt, 
2001).  Therefore, changes in the proximity to the synapses from astrocyte 
processes likely influence the concentration of glutamate, which can directly 
modify synaptic transmission.  In fact, reduced astrocyte contact with dendritic 
spines was observed during spine head remodeling and pharmacological 
blockade of astrocyte glutamate transporters prevented spine remodeling in 
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mouse hippocampal slices (Verbich et al., 2012).  Despite the importance of 
astrocyte association with synapses for CNS function, we know almost nothing 
about how astrocytes regulate morphological changes in response to neural 
activity or changes in circuit needs. 
 
Astrocytes and epilepsy 
Brain network activity maintains the balance between excitation and inhibition to 
precisely encode and deliver information.  Epilepsy is a prevalent neurological 
disorder that is characterized by the unpredictable and spontaneous seizures 
(Thurman et al., 2011).  Seizures are caused by an imbalance between 
excitatory and inhibitory synaptic activity resulting in neuronal network 
hyperexcitability (Jefferys, 1990; Pinto, 2005; Robel et al., 2015).  Therapeutic 
effort has been made to control epileptiform activity by directly targeting neuronal 
activity using general CNS depressants (Binder and Steinhäuser, 2017).  
However one third of patients become medically refractory and often their 
cognition is affected by current therapeutic approaches that are neuron centric 
(Binder and Steinhäuser, 2017; Wahab et al., 2010).  Therefore, there is a need 
for the development of more specific therapeutics, which requires better 
understanding of the cellular and molecular mechanisms underlying epileptic 
seizures. 
 Alterations in astrocytic structure and function in epilepsy have been well 
characterized (Bedner et al., 2015; Bordey and Sontheimer, 1998; de Lanerolle 
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et al., 2010; Robel et al., 2015; Ye et al., 1999).  These alterations include 
distinct changes in astrocytic morphology, expression, subcellular localization 
and function of K+ and water channels, glutamate transporters and glutamine 
synthetase (GS) in the epileptic brain (Seifert and Steinhäuser, 2013).  
Accordingly, astrocytes need to be included in the equation to understand 
neuronal hyperexcitability in seizure.  
 Maintenance of proper extracellular [K+] is crucial to shape neuronal 
activity and maintain network balance and it heavily depends on astrocytic K+ 
and water channels (Kofuji and Newman, 2004).  Studies in epileptic human 
hippocampus suggest that altered expression in astrocytic Kir channels resulted 
in the impaired K+ buffering and enhanced seizure susceptibility (Hinterkeuser et 
al., 2000; Kivi et al., 2000).  These Kir channels show spatial overlap with the 
water channel, aquaporin 4 (AQP4) in astrocytes (Nielsen et al., 1997) and AQP4 
knockout mice are impaired in K+ buffering and prolong seizure duration (Binder 
et al., 2006).  These findings indicate that impaired water channels together with 
decreased expression of Kir channels in astrocytes are responsible for loss of K+ 
buffering and increase in seizure susceptibility.  
 Another key mechanism to balance network activity is proper clearance of 
neurotransmitters at the synaptic cleft.  In particular removing excess glutamate 
by glutamate transporters in astrocytes is a fundamental mechanism to terminate 
excitatory synaptic signal and keep the balance between excitation and inhibition 
(Seifert and Steinhäuser, 2013).  Impaired activity of the astrocytic transporters, 
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EAAT1 and EAAT2 and a consequent increase in extracellular glutamate are 
common features of epilepsy (Glass and Dragunow, 1995; Seifert et al., 2006).  
Studies using inhibitors of glutamate transporters suggested that astrocytic 
control of ambient glutamate is critical for the genesis and maintenance of 
seizure activity (Nyitrai et al., 2010; Seifert and Steinhäuser, 2013).  In addition to 
glutamate transporters, glutamine synthetase (GS) in astrocytes plays an 
important role in glutamate clearance.  This astrocyte specific enzyme converts 
glutamate into glutamine that is glutamate receptor-inactive.  Its alteration that is 
accompanied by increased extracellular glutamate levels is observed in epilepsy 
(Eid et al., 2008; Hammer et al., 2008; Seifert and Steinhäuser, 2013).  
Glutamate to glutamine conversion by GS is also essential for GABA synthesis 
and its synaptic release to regulate inhibitory synaptic activity (Liang et al., 2006).  
Decreased inhibitory tone by impaired GS expression resulted in hyperactivity 
and seizure (Ortinski et al., 2010).  
 Mounting evidence demonstrates altered astrocyte function in human and 
rodent models of epilepsy.  However, a lack of available tools in mammalian 
systems for precisely manipulating astrocytic function makes it challenging to 
answer critical questions including whether these alterations are causative or not 
and mechanisms underlying these alterations.   
 
Drosophila as a model system to study astrocytes 
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Astrocytes contribute to virtually every aspect of nervous system development 
and function.  Despite this notion, our understanding of how and why astrocytes 
do what they do is nowhere near complete.  To accelerate our understanding of 
astrocytes the field needs to embrace model organisms like Drosophila.  Over 
the last two decades it has become clear that astrocyte biology changes 
dramatically when these cells are removed from their in vivo context 
(Balasubramanian et al., 2016; Foo et al., 2011; Götz et al., 2015).  Studying 
these cells in intact circuits in vivo will therefore be essential if we wish to unravel 
the nature of astrocyte-neuron and astrocyte-vasculature interactions. 
 
Advantages of Drosophila as a model organism 
Foundational reasons to use Drosophila to study the biology of astrocytes in the 
context of circuit behavior include full access to their annotated genome 
sequence and substantial gene conservation with humans (Adams et al., 2000).  
In addition, it has been estimated that about 75% of human disease related 
genes have conserved orthologs in flies (Lloyd and Taylor, 2010; Reiter et al., 
2001).  A comparison of conserved functional domains between a fly and a 
human in a given gene suggests that the homology is in fact even higher, 
approaching 80 to 90 % (Pandey and Nichols, 2011).  A simplified genome 
compared to humans also gives less redundancy, reducing complications in data 
interpretation during genetic analysis (Adams et al., 2000). 
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Over 100 years of history in using Drosophila melanogaster in modern 
biological sciences have accumulated resources for easy genetic manipulations. 
By far, the most appreciated milestone for genetics is the introduction of the 
GAL4/UAS system by Brand and Perrimon (1993).  It utilizes the yeast 
transcriptional activator GAL4 that is flanked by a defined promoter to activate a 
transgene of interest under the control of the upstream activation sequence 
(UAS), the target of GAL4. This cell type–specific molecular genetics, along with 
the development of reliable GAL4 driver lines for subsets of glia (Stork et al., 
2011) allows for a new level of examination in astrocytic contribution to brain 
function in vivo.  A further expansion has been made in terms of reverse genetic 
analysis since the development of transgenic fly lines carrying a UAS-regulated 
transgene expressing RNAi for almost every single gene in Drosophila genome 
(Dietzl et al., 2007; Ojelade et al., 2014).  These resources not only allow for 
rapid testing of any genes involved in a given biological process but also give a 
chance to perform a large-scale screen, which can be a powerful approach to 
find novel genes mediating a pathway of interest.  
The rapid life cycle of flies cannot be overlooked. A single reproductive 
pair can generate hundreds of eggs and it takes 10 to 12 days for these offspring 
become reproductive adults. Compared to rodent models that only produce a 
handful of offspring every 3 to 4 months, this is a great advantage to facilitate a 
study (Pandey and Nichols, 2011). Defined developmental stages of Drosophila 
include the embryo, the larva, the pupa, and the adult and each stage provides 
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unique experimental advantages.  The embryo has been a great platform to 
study cell fate determination, cellular development, and organogenesis.  The 
larva, the wandering third instar larva in particular has been popular to study 
developmental and physiological processes.  Furthermore easy tissue extraction 
and simple behavioral patterns will invite even more studies of circuit level 
questions.  Researchers have already recognized the great advantage of using 
the pupa to investigate glial roles in neural circuit remodeling (Muthukumar et al., 
2014; Tasdemir-Yilmaz and Freeman, 2014).  Finally the discreet circuits in adult 
flies mediate complex behaviors including circadian rhythms, learning and 
memory, courtship, feeding, aggression, grooming, and flight navigation and they 
are suggested to be a great potential platform for drug screening (Pandey and 
Nichols, 2011). 
 
Drosophila CNS glia  
The Drosophila nervous system is relatively simple, but houses excitatory and 
inhibitory neurons that are remarkably similar to their mammalian counterparts in 
terms of their development, mechanisms of synaptic release, and major 
neurotransmitter systems used (Freeman, 2015).  The glia to neuron ratio in 
mouse is ~55% glia to ~45% neurons (averaged across the entire brain), while in 
Drosophila glia make up only ~10-15% of all the cells in the nervous system 
(Awasaki et al., 2008; Ito et al., 1995; Pfrieger and Barres, 1995).  The 
Drosophila CNS can be divided into two parts: the neuronal cell cortex where all 
 23 
the cell bodies sit, and the neuropil where axons and dendrites form synapses 
(Freeman, 2015).  Glial cells in Drosophila are characterized according to their 
position, morphology and association with neurons.  The outermost layer of the 
CNS is surrounded by perineural glia (PG) that function as a chemical and 
physical barrier for the CNS (Carlson et al., 2000).  Beneath the PG is the layer 
of subperineural glia (SPG), which form pleated septate junctions with one 
another to establish and maintain the blood-brain barrier (BBB) (Freeman, 2015; 
Stork et al., 2011).  Within the domain of the BBB there are three major glial cell 
types that form intimate associations with neurons and mediate neural circuit 
assembly, function, plasticity, and behavior.  Cortex glia infiltrate the cortex 
region to surround all neuronal cell bodies and the proximal regions of neuronal 
processes (Coutinho-Budd et al., 2017; Ito et al., 1995).  Ensheathing glia reside 
right along the boundary between the cortex and neuropil to help separate these 
discrete anatomical compartments (Dumstrei et al., 2003).  One of the most 
recognized functions of ensheathing glia is the injury induced response they 
exhibit after axotomy, which is mediated the Draper/Src-family kinase signaling 
cascade (Awasaki et al., 2006; Doherty et al., 2009; MacDonald et al., 2006; 
Ziegenfuss et al., 2012).  Together with cortex glia, ensheathing glia are also 
critical for CNS development, in particular for proper positioning and survival of 
neuronal cell bodies and formation of major axon tracts (Dumstrei et al., 2003; 
Spindler et al., 2009).  
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 Astrocytes are found within the synaptic neuropil and have direct 
association with neuronal processes and synapses.  Their tufted morphology and 
tiling behavior is highly reminiscent of mammalian protoplasmic astrocytes 
(Awasaki et al., 2008; Doherty et al., 2009; Stork et al., 2014; Tasdemir-Yilmaz 
and Freeman, 2014), and they serve very similar functional roles.  During 
metamorphosis, larval neural circuits undergo major remodeling.  After 
deconstruction and clearance of the circuits, adult CNS starts to be formed by 
massive synaptogenesis which is coordinated by astrocytes (Freeman, 2015; 
Muthukumar et al., 2014).  These results strongly suggest that just like their 
mammalian counterparts, Drosophila astrocytes play a crucial role in synapse 
formation during CNS development.  During this dramatic remodeling in the larval 
CNS, astrocytes become highly phagocytic by increasing the expression of 
engulfment receptor, Draper and engulf pruned axons, dendrites, and synapses 
(Hakim et al., 2014; Tasdemir-Yilmaz and Freeman, 2014).  Interestingly, pruning 
in the mammalian retinogeniculate system is activated during remodeling by 
astrocyte secretion of TGF-β (Bialas and Stevens, 2013), and astrocyte secretion 
of TGF-β (Myoglianin, Myo) is necessary and sufficient to initiate neuronal 
pruning in Drosophila mushroom body (Awasaki et al., 2011).  
 Drosophila astrocytes also play important roles in neurotransmitter 
clearance at synaptic cleft to modulate network activity and behavior.  They 
express transporters to take up glutamate (EAAT1), GABA (Gat), and enzymes 
(glutamine synthetase and GABA transaminase) to metabolize them once they 
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are taken up (Freeman et al., 2003; Rival et al., 2004; Stacey et al., 2010; Stork 
et al., 2014).  Genetic depletion of EAAT1 in glia leads to impaired synaptic 
transmission and locomotion in larvae (Stacey et al., 2010) and excitotoxicity-
induced neurodegeneration in adult flies (Rival et al., 2004).  Knockdown of Gat 
expression in astrocytes causes severe locomotion defects in larvae and adults 
and complete removal of Gat leads to animal lethality (Stork et al., 2014).  These 
data suggest neurotransmitter transporters in Drosophila, like mammals, play 
critical roles in E/I balance, but mechanisms regulating their expression and 
function remain poorly defined. 
The field has achieved remarkable progress in identifying astrocytes as 
dynamic signaling elements that have impact on neuronal circuit formation and 
maintenance.  However, the detailed cellular and molecular mechanisms of such 
regulations during different conditions like physiological or pathological conditions 
are still elusive.  In this thesis, through in vivo behavioral screen, we identified 
astrocytic genes governing astrocyte functions in regulating neuronal network 
activity. 
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Chapter 2: In vivo RNAi screen for astrocytic factors to 
regulate neuronal activity using a genetic model of 
seizure 
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Introduction 
Astrocytes are now a well-recognized cell type in the nervous system for their 
critical roles in neuronal network homeostasis.  Astrocytes give metabolic support 
to neurons, buffer ions and pH, and removal of neurotransmitters.(Kimelberg and 
Nedergaard, 2010).  Their tufted morphology has been determined to be 
important for many of their functions.  Especially, the distal fine processes of 
astrocytes compose 80% of their membrane and are filled with ion channels, 
neurotransmitter receptors, and transporters.  They infiltrate into the neuropil, 
where synapses are and communicate with neurons and modulate synaptic 
activity (Chung et al., 2015; Halassa and Haydon, 2010; Stork et al., 2014).  
Astrocytes alter their structural organization and functions in response to 
neuronal activity to accommodate and participate in a changing network 
environment (Theodosis et al., 2008).  However, the precise mechanisms 
through which astrocytes change their morphological and functional features and 
the molecules required in astrocyte-neuron crosstalk have only started to be 
discovered.  In vivo observation in particular, remains to be a major challenge in 
decoding the roles of astrocytes in brain function (Haydon and Nedergaard, 
2014).  
Drosophila is a great model system to overcome the limitations and 
challenges of studying astrocyte function in vivo and accelerate the growth of the 
field.  The Drosophila nervous system is relatively simple compared to 
mammalian counterparts yet they share a number of glial characteristics 
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including molecular basis, functions, and morphology (Doherty et al., 2009; 
Freeman et al., 2003; Murai and van Meyel, 2007; Muthukumar et al., 2014; 
Stork et al., 2014).  A phalanx of genetic tools available in the fly will allow us to 
specifically label and manipulate astrocytes in vivo and decipher their roles within 
the neuronal network in an intact brain.  
To first identify astrocyte genes required for modulating neuronal activity 
using Drosophila, we performed an in vivo candidate screen in adult flies with 
RNA interference (RNAi).  Considering that astrocyte functions heavily rely on 
their transmembrane proteins including channels, receptors, and transporters 
(Araque et al., 1999), we selected about 2,000 Drosophila transgenic UAS-RNAi 
lines from Vienna Drosophila Resource Center (VDRC) targeting mostly genes 
coding for secreted, transmembrane or membrane associated proteins (Dietzl et 
al., 2007).  Then, to achieve astrocyte-specific RNAi expression, we used an 
astrocyte-specific Gal4 line, alrm-Gal4 (Doherty et al., 2009), to drive UAS-RNAi 
from the chosen library.  
As a tool to manipulate neuronal activity in vivo, we took advantage of a 
sensitized genetic background in which neuronal hyperexcitability-mediated 
seizure can be induced by simple mechanical shock (Pavlidis et al., 1994).  A 
bang-sensitive mutation, easily-shocked (easPC80) is a well-established model to 
study neuronal hyperexcitability and seizure in the Drosophila nervous system 
(Parker et al., 2011; Pavlidis et al., 1994).  The loss-of-function of ethanolamine 
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kinase disrupts the metabolism of phosphatidylethanolamine which is one of the 
prevalent membrane lipids (Lim et al., 2011; Pavlidis et al., 1994).  
These mutant flies display seizure-like behaviors characterized by initial seizure, 
temporary paralysis, and recovery seizure when electrical or mechanical shock, 
“bang” is introduced (Benzer, 1971; Ganetzky and Wu, 1982) and this Drosophila 
model of seizure has a significant similarities with human seizures (Parker et al., 
2011).  Electrophysiological recordings on the mutant flies show 5 times lower in 
their seizure threshold compared to wild-type flies suggesting hyperexcitability in 
their neuronal network (Kuebler and Tanouye, 2000).  In addition, this fly strain 
carrying a mutation in ethanolamine kinase suffers from hyperexcitability and 
paralysis resulting in loss of postural control, being unable to right themselves 
when exposed to a brief mechanical shock (e.g. 10 sec of vigorous vortexing).  
Following the mechanical bang, mutant flies require recovery time around 110 
seconds while control flies need no recovery time to right themselves up and 
resume their normal activities like grooming and climbing on the culture vials 
(Parker et al., 2011; Pavlidis et al., 1994).  
Ethanolamine kinase is suggested to play an important role in nervous 
system development since easPC80 impairs proper development of mushroom 
body α/β lobes (Pascual et al., 2005a).  However, later studies elaborated that 
these developmental changes were not indicative of seizure sensitivity but 
increased ratio of excitatory and inhibitory activity was suggested as a seizure 
inducing mechanism (Kroll and Tanouye, 2013a).  Thus, assaying for this distinct 
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behavioral phenotype in easPC80 can provide a robust platform to define genes 
that modify seizure sensitivity when they are depleted in astrocytes.   
We identified 100 RNAi lines that suppress hyperexcitability induced 
seizure-like behavior when they are expressed in astrocytes and 87 lines 
enhanced seizures in the easPC80 genetic background. 
 
Results 
An in vivo RNAi screen identifies potential astrocyte-expressed regulators 
of seizure-like behavior 
To identify novel astrocyte genes capable of modulating neural circuit activity, we 
performed an in vivo RNAi screen in adult Drosophila to identify astrocyte genes 
that enhance or suppress seizure when they are knocked down.  We took 
advantage of the easily shocked (easPC80) mutant, a well-studied seizure model 
that belongs to the bang-sensitive (BS) paralytic class.  It provides a sensitized 
genetic background in which neuronal hyperexcitability and ultimately seizure 
activity can be induced by simple application of mechanical force (Pavlidis et al., 
1994) providing a convenient platform for the screen.  Out of three BS mutants 
that have been the most utilized as experimental representatives (The 
Slamdance, the easily shocked, and tha bang senseless1 ),  easily shocked 
mutant shows moderate seizure sensitivity which allows us to define both 
suppressors and enhancers for seizure sensitivity during the screen.  Our target 
collection of RNAi lines consisted of ~2,000 constructs that targeted genes 
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encoding the majority of secreted, transmembrane, or membrane-associated 
molecules in the fly genome (Dietzl et al., 2007).  Astrocyte-specific knockdown 
of each gene was accomplished using the alrmGal4 driver (Doherty et al., 
2009)(Fig2 b).  Application of mechanical shock (i.e. vortexing of animals in 
culture vials for 10 seconds) has no effect on control animals, which means they 
immediately resume normal motor activity after the shock.  In contrast, the same 
stimuli resulted in easPC80 mutants experiencing broad neuronal hyperexcitability 
and paralysis, and they exhibit a mean recovery time of approximately 110 
seconds (Pavlidis et al., 1994)(Fig 2A).  We crossed individual males from UAS-
RNAi lines to virgin easPC80, alrmGal4 females, and collected up to 15 male 
progenies that are 1 to 5 days old post eclosion in a clean vial (i.e. easPC80/y; 
alrm-Gal4/+ and also contained a single copy of the UAS-RNAi construct being 
assayed).  The next day, collected flies were transferred to a clean empty vial 
and recover for at least 2 hrs from any mechanical shock that may have 
introduced during transfer.  Animals were then vortexed for 10 seconds and the 
percent of animals that righted themselves were scored at 1, 1.5, 2, 3, and 4 
minutes (Fig. 2A).  Since easPC80 animals required about 110 sec to reach 100 % 
recovery from bang-induced seizure-like behavior, 4 min of total assay time 
allowed us collect suppressors as well as enhancers for this behavior. 
We scored suppressors as UAS-RNAi lines that led to strong recovery 
within 1.5 minutes, and enhancers as UAS-RNAi lines that had less than 90 % 
recovery until after 4 min.  Then, only the ones that had at least 10 flies as a total 
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number of animals tested made it to the final list of hits. In total, we identified 100 
RNAi lines (4.6 % out of all the lines tested) that suppressed seizure activity and 
87 lines (4.0 %) that enhanced seizures in the easPC80 genetic background when 
expressed in astrocytes (Fig. 2B).  
The lists of potential suppressors and enhancers (Table 1 and 2) were 
subjected for protein functional categorization using PANTHER classification 
system (Mi et al., 2013).  91 genes out of 100 scored as suppressors and 78 out 
of 87 genes scored as enhancers had defined molecular functions based on the 
database.  From both suppressors and enhancers, major portions of genes were 
suggested to function as transporters (34.5 % of suppressors and 24.6 % of 
enhancers)(Fig 2C, D).  Further validation is necessary to confirm the effect of 
RNAi perhaps using second RNAi that targets different sequences since a 
handful of RNAi lines are predicted to have off-targets. 
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Figure 2: Schematics of the screen and summary of the results 
A, Schematics of the behavioral assay using Drosophila bang-sensitive mutant, 
easPC80 for RNAi based screen.  B, Astrocyte specific knockdown utilizing 
GAL4/UAS system and summary of screen results.  C, Pie charts represent 
candidate genes categorized based on their protein function.  100 suppressors 
were identified as genes that cause flies recover 100 % from the 
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hyperexcitability-induced seizure by 90 seconds when RNAi for target gene is 
expressed in astrocytes.  Protein functional categorization was done by the 
PANTHER classification system (Mi et al., 2013).  91 genes that have defined 
function were subjected for categorizations.  D. Enhancers are defined when flies 
with a RNAi showed less than 90 % recovery by 4 minutes which is the total 
length of assay.  78 genes out of 87 genes were subjected for categorizations. 
 
Discussion 
We identified astrocyte-expressed genes that regulate CNS physiology in the 
context of hyperexcitability by assaying for modification of seizure-like behavior 
using the well-characterized bang-sensitive mutants (Pavlidis et al., 1994).  While 
the precise mechanism to induce network hyperexcitability by the genetic seizure 
model (easPC80) used in our screen is not completely understood, studies with 
cell-type specific rescues suggests a role for eas+ in excitatory rather than 
inhibitory transmission (Kroll and Tanouye, 2013b).  Therefore, the imbalance of 
the network activity supposedly comes from enhanced excitation rather than 
decreased inhibition and the hits from our screen would act either by decreasing 
excitation or increasing inhibition to ameliorate network imbalance.  Our 
collection of RNAi lines targeted the vast majority of transmembrane, secreted, 
and signaling molecules encoded in the Drosophila genome.  While we focused 
our further analysis on FA molecules (see Chapter 3), a few additional classes of 
molecules were found repeatedly in our collection of enhancers or suppressors 
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(Fig 2, Table 1, 2).  For instance, ~40% of the suppressors of seizure activity 
were transporters or transfer/carrier proteins, while ~9% were transmembrane 
receptors.  Similarly, ~25% of the enhancers fell into the transporter class, and 
~12% were transmembrane receptors (Fig 2C, D).  In many species astrocytes 
have been found to express a wide array of transporters (Amara and Kuhar, 
1993; Aroeira et al., 2013; Doherty et al., 2009; Hanu et al., 2000; Malynn et al., 
2013; Martin and Krantz, 2014; Raiteri et al., 2008; Stork et al., 2014; Suzuki et 
al., 2011), but the in vivo activity and role of these molecules has not been 
explored in detail, perhaps with the exception of Excitatory amino acid 
transporters (EAATs) and γ-aminobutyric acid transporters (GATs).  
Transmembrane receptors, particularly those that bind neurotransmitters, have 
been the focus of a number of recent studies exploring how astrocytes directly 
respond to neurotransmitters.  Our work suggests a deeper analysis of this class 
of molecules could shed important new light on how astrocytes modulate central 
nervous system (CNS) excitability and signaling.   
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Materials and Methods 
Fly strains.  The following Drosophila strains were used: w1118 Canton S, alrm-
GAL4(Doherty et al., 2009), easPC80(Pavlidis et al., 1994).  
UAS-RNAi lines were from Vienna Drosophila Resource Center (Vienna, 
Austria). 
 
Bang-sensitive behavioral assay.  The behavioral assay was modified from 
Song et al. (2008) and described in Muthukumar et al. (2014).  Adult male flies 
after 3-7 days of eclosion were collected in fresh food vials the night before 
experiments.  Vials containing 10 – 15 flies were subjected to mechanical 
stimulus using a VWR Vortex Mixer (VWR International, West Chester, PA) at 
maximum speed for 10 sec to induce paralysis and seizure in bang-sensitive 
mutant, easPC80.  The numbers of flies standing and resuming normal behavior 
was noted at 10 s intervals for 4 min.  Mean recovery time was calculated as the 
average time taken by an individual fly to recover from paralysis. 
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CHAPTER 3: Tensin and other focal adhesion 
associated molecules as a regulator of seizure-like 
behavior 
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Introduction 
Astrocytes are highly branched non-neuronal cells that tile with one another and 
densely infiltrate nearly all synapse rich regions of the brain.  The fine 
membranes of astrocytes form close contacts with neuronal cell bodies and 
synapses, where they support and modulate neuronal activity.  Astrocytes 
provide metabolic support to neurons to meet the high energy demands of neural 
activity, and buffer ions and pH to maintain brain homeostasis (Kimelberg and 
Nedergaard, 2010).  Through dynamic changes in calcium signaling, astrocytes 
act as important regulators of neural activity (Khakh and McCarthy, 2015; Ma et 
al., 2016) and neuro-vascular coupling (Daneman and Prat, 2015).  Despite our 
growing appreciation for the importance of astrocytes in neural circuit function 
and maintenance (Chung et al., 2015; Halassa and Haydon, 2010), we know 
surprisingly little about the signaling pathways regulating astrocyte associations 
with synapses or how they are modulated by dynamic changes in activity. 
A major mechanism by which astrocytes impact synaptic physiology is 
through the regulation of extracellular levels of excitatory and inhibitory 
neurotransmitters.  Following neuronal release of glutamate or GABA, excitatory 
amino acid transporters (EAATs) or GABA transporters (GATs), respectively, on 
astrocyte membranes remove these NTs from the synaptic and extra-synaptic 
space (Danbolt, 2013).  Efficient astrocyte clearance of NTs is important for 
proper termination of synaptic signaling to avoid, for instance, chronic receptor 
desensitization at synpases (Pita-Almenar et al., 2012; Rothstein et al., 1996; 
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Stacey et al., 2010), regulation of the spillover of neurotransmitters between 
synapses (Danbolt, 2013; Kersanté et al., 2013; Pál, 2015), and for setting 
proper basal excitatory/inhibitory (E/I) tone (Muthukumar et al., 2014; Tanaka et 
al., 1997; Zeng et al., 2010).  Conditional elimination of EAATs from astrocytes in 
mouse results in fatal epilepsy (Petr et al., 2015), and mutations in human 
EAATs cause episodic ataxia and seizure (de Vries et al., 2009). 
EAATs on astrocyte membranes appear to be subject to diverse modes of 
regulation.  EAAT levels change in response to factors secreted from neurons 
including glutamate (Gegelashvili et al., 1996) , neuronal contact (Swanson et al., 
1997), or neuronal activity (Genoud et al., 2006; Pannasch et al., 2014; Perego 
et al., 2000).  Pathological changes in EAATs have been associated with disease 
including epilepsy and seizure (Tanaka et al., 1997), neurodevelopmental 
disorders (Higashimori et al., 2016), ataxia (de Vries et al., 2009; Parinejad et al., 
2016) and ALS (Rothstein et al., 1995), where dysregulation of EAATs is thought 
to drive changes in E/I balance.  Treatments that upregulate GLT1 (the astrocyte 
EAAT2 in human) expression in vitro show neuroprotective effects (Rothstein et 
al., 2005), arguing that rebalancing EAAT levels may be a valuable therapeutic 
approach to reestablish normal E/I balance.  However, precision in tuning EAATs 
will be essential: for example, increasing GLT1 expression in vivo, through 
application of β-lactam, ceftriaxone, or interfering with neuroglia EphA signaling, 
had no effect on basal excitatory synaptic transmission, but resulted in impaired 
long-term plasticity and learning and memory performance (Carmona et al., 
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2009; Omrani et al., 2009; Rothstein et al., 2005), presumably because 
glutamate levels were not sufficiently high to drive synaptic strengthening.  
From our comprehensive in vivo RNAi screen in Drosophila to identify astrocyte-
expressed genes that could phenotypically modify a genetically induced seizure 
model, focal adhesion molecule called tensin has emerged as a strong 
suppressor.   
 Focal adhesions are multi-protein complexes in which integrins have a 
central role in linking the extracellular matrix (ECM) with the actin cytoskeleton.  
The cytoplasmic side of focal adhesions is composed of multiple adaptor 
proteins, which connect the cytosolic tail of β-Integrin to the actin cytoskeleton 
(Lo, 2006).  Studies in mice fibroblasts show that the dynamic nature of focal 
adhesions enables them to mediate cell motility and membrane protrusion by 
rearranging the actin cytoskeleton (Le Clainche and Carlier, 2008; Lin et al., 
1994).  In response to extracellular stimuli, a trigger of actin signaling is mediated 
by focal adhesions to drive changes in cell shape and membrane protrusion.  
Dynamic formation of focal adhesions would be expected to account for actin-
dependent cellular processes (Jovceva et al., 2007).  In cultured astrocytes, 
activation of Eph receptor tyrosine kinases increases the number of focal 
adhesions along with cytoskeletal reaarangement (Puschmann and Turnley, 
2010).  Another study suggests treatment of the thyroid hormone, thyroxine (T4) 
which has an essential role in the growth and development of the mammalian 
brain increases the number and length of focal adhesions by promoting integrin 
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clustering in astrocytes (Siegrist-Kaiser et al., 1990).  While focal adhesions have 
been analyzed in cultured astrocytes it is not known if focal adhesions play 
important roles for the establishment or maintenance of the complex morphology 
of astrocytes and their functions in relation to neuronal activity in vivo.  
With a further analysis, we found that astrocyte-specific depletion of other 
components of focal adhesion complexes (FAs) and a matrix metalloproteinase 
potently suppressed seizure activity, and this suppression further expanded to a 
pharmacologically induced model of seizure (i.e. picrotoxin exposure).  We 
provide evidence that under normal physiological conditions FAs are required for 
proper establishment of astrocyte coverage of the synaptic neuropil and 
expression of EAAT1, but they do not regulate the sole Drosophila GAT 
molecule.  Interestingly, in the context of hyperexcitability, FAs negatively 
regulated EAAT1 levels and astrocyte coverage, and their elimination led to 
enhanced EAAT1 expression, increased astrocyte coverage of the synaptic 
neuropil, and more rapid recovery from seizure.   
 
Results 
An in vivo RNAi screen identifies tensin as an astrocyte-expressed 
regulator of seizure activity 
In our primary screen we found that astrocyte-specific knockdown of tensin, an 
essential component of focal adhesion complexes (FAs) and regulator of cell-
extracellular matrix interactions, led to mean recovery times of less than 1.5 min.  
 42 
We repeated the easPC80 seizure assay with multiple tensinRNAi lines, in this case 
recording recovery rates at 10 sec intervals.  We noticed a dramatic shift of 
recovery curve with astrocyte-specific expression of tensinRNAi compared to 
controls (Fig 3.1A) and a decrease in mean recovery time with astrocyte 
tensinRNAi (Fig 3.1A’). 
 To determine the pattern of Tensin localization in astrocytes we visualized 
Tensin using an endogenously GFP-tagged tensin line, and labeled astrocyte 
membranes with anti-Gat antibodies in 3rd instar larva ventral nerve cords (Fig 
3.1B).  We found that Tensin-GFP was localized in punctate structures in 
astrocyte cell bodies and astrocyte processes as they projected into the neuropil 
area among neuronal circuits.  To determine whether our tensinRNAi lines were 
indeed targeting tensin, we quantified Tensin-GFP levels in astrocytes in controls 
and animals expressing UAS-tensinRNAi under the control of alrmGAL4.  To 
selectively examine astrocyte Tensin-GFP we focused on the quantification of 
Tensin-GFP that fell within the domains of anti-Gat immunoreactivity (i.e. the 
Tensin within astrocytes).  We found that Tensin-GFP levels were decreased by 
38 percent in tensinRNAi animals compared to its control (Fig 3.1B’).  Furthermore, 
when we expressed UAS-tensinRNAi under the control of tubulin-GAL4, Tensin-
GFP punctae were not detectable (Fig 3.1C).  These data demonstrated that 
Tensin is expressed in astrocytes, localized to punctate structures within 
astrocytes, and that our RNAi lines successfully targeted tensin expression.  We 
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conclude that Tensin is a novel astrocyte molecule that can modulate seizure-like 
behavior in vivo.   
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Figure 3.1: Tensin, a focal adhesion molecule potently suppresses seizure-
like behavior when knocked down in astrocytes 
A, Percent of recovery is measured every 10 sec following 10 sec of mechanical 
shock.  Wide-type flies are not affected by the shock so their recovery is 100 % in 
10 sec while easPC80 displays seizure-like behavior requiring time to recover.  
Knockdown of astrocyte focal adhesion molecule, tensin suppresses seizure-like 
behavior in bang-sensitive mutant.  Two RNAi lines that are targeting different 
sequences were tested.  A’, Mean recovery time is measured based on data 
shown in A.  Error bars represent SEM.  **P<0.005, ****P<0.0001; one-way 
ANOVA and Dunnett’s multiple comparisons.  N > 100 flies quantified for all 
genotypes.  B, Tensin signal is visualized with GFP that is genetically tagged and 
astrocyte membrane is labeled using α-Gat antibody in control and astrocyte 
tensin knockdown.  B’, Knockdown efficiency by RNAi is quantified by measuring 
the intensity of tensin::GFP signal in astrocyte membrane.  Error bars represent 
SEM.  **P<0.01; unpaired t test.  alrmGAL4/+, N = 8; alrmGAL4>UAS-tensin 
RNAi, N = 6 animals quantified.  C, Expressing tensin RNAi with TubGAL4 driver 
removed Tensin::GFP punctae throughout the ventral nerve cord of 3rd instar 
larvae.  TubGAL4/+, N = 8; TubGAL4>UAS-tensin RNAi, N = 7 aniamls.  
Scale bars represent 10 µm in B and C. 
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Multiple components of focal adhesion complexes function in astrocytes to 
modulate seizure activity 
Tensin is a component of FAs, which are large multi-protein complexes that 
include heterodimeric integrin receptors that interact with ECM, and adaptor 
proteins that connect integrin receptors to the actin cytoskeleton (Fig 3.2A).  We 
sought to determine whether additional known FA molecules functioned in 
astrocytes to modulate hyperexcitability-induced seizure behavior. 
Integrins are the central players of focal adhesions and composed of 
heterodimeric α- and β- subunits.  The cytosolic tail of β-integrin serves as an 
anchor to multiple adaptor proteins in the focal adhesions (Le Clainche and 
Carlier, 2008).  In Drosophila, there is only one βintegrin called βPS as opposed 
to αintegrin with five different subunits and βintegrin is sufficient to initiate a 
signaling pathway in the developing embryo (Martín-Bermudo and Brown, 1999).  
To address roles of integrins as a focal adhesion in astrocytes and their functions 
in seizure-like behavior, we choose to look at βintegrin that is unlikely to 
complicate the interpretation of data with redundancy.  Immunofluorescent 
labeling with anti-βintegrin antibodies revealed that βintegrin colocalized with 
Tensin-GFP+ punctae within ventral nerve cord (Fig 3.2B), which supports the 
notion that Tensin protein is largely associated with βintegrin containing FAs.   
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We next screened well defined FA components in the adult easPC80 assay 
and found that RNAi knockdown of adaptor protein, Talin or focal adhesion 
kinase (FAK), as well as βintegrin in astrocytes strongly suppressed seizure 
behavior at levels similar to tensinRNAi (Fig 3.2C, C’).  These results further 
support the notion that FAs in astrocytes regulate nervous system 
hyperexcitability and seizure behavior. 
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Figure 3.2: Multiple components of focal adhesion complexes function in 
astrocytes to modulate seizure-like behavior 
A, Schematics of focal adhesions (only components that are discussed in this 
study are shown).  B, Confocal image shows colocalization of tensin and 
βintegrin in the ventral nerve cord of 3rd instar larvae.  Tensin signal is genetically 
tagged with GFP and βintegrin signal is detected by α-βPS antibody.  N = 19 
animals.  C, Mutiple components of focal adhesions including βintegri, talin, and 
FAK showed similar suppression tensin in the adult behavioral assay when they 
are depleted in astrocytes using RNAi.  C’, Quantification of mean recovery time 
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from data C.  Error bars represent SEM. ****P<0.0001; one-way ANOVA and 
Dunnett’s multiple comparisons.  N > 100 flies quantified for all genotypes.  
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Seizures induced by pharmacological blockade of GABA-A receptors are 
modulated by astrocyte focal adhesions 
To complement our studies using the easPC80 genetic model of seizure we turned 
to pharmacological blockade of GABA-A receptor signaling.  Exposure of larvae 
to food containing the GABA-A receptor inhibitor picrotoxin (PTX) results in 
widespread CNS disinhibition, an overall increase in neuronal activity, and larval 
nervous system hyperexcitability (Stilwell et al., 2006).  This pharmacological 
model of seizure has a precise mechanism of action because of the specificity of 
the inhibitor and an easy in vivo delivery in Drosophila larvae gives us a great 
advantage to control the action of drug in terms of concentration and exposure 
time (Stilwell et al., 2006).  We collected 3rd instar larvae and allowed them to 
consume PTX-laced or control food for a period of 9 hrs, and we compared sham 
animals to animals treated with two different doses of PTX (0.5 or 1.5 mg/ml).  
We observed no changes in baseline motility in animals that were sham treated, 
and no alterations in baseline motor function after astrocyte-specific knockdown 
of tensin, βintegrin, talin, or FAK (Fig 3.3A, B).  Therefore depletion of FA 
signaling components in astrocytes did not appear to alter baseline motor 
behavior in crawling assays.  We observed a dose-dependent decrease in 
motility in control animals, with velocity (mm/min) being decreased by 65% after 
exposure to 0.5 mg/ml PTX, and further decreased by 83% after exposure to 1.5 
mg/ml PTX (Fig 3.3A, B).  In contrast, PTX-induced decreases in larval motility 
were partially but significantly suppressed at both doses in animals with 
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astrocyte-specific RNAi depletion of tensin, βintegrin, talin, or FAK (Fig 3.3A, B).  
Since PTX was delivered with food, the possibility of impairment of animal 
feeding behavior by RNAi was explored.  Using food coloring, when larvae were 
subjected to 9hr of food consumption, the relative food intake measured by 
spectrophotometry was comparable across genotypes (Fig 3.4A) suggesting the 
amount of PTX delivered into the system is not accountable for the RNAi effect 
on the behavior.  When we only expressed UAS-RNAis to control the insertion of 
UAS-RNAi construct, the suppression effect on PTX-induced decrease in larval 
locomotion was absent (Fig 3.4B).  To overcome the concerns for expressing two 
UAS-RNAi at the same time, we utilized the tensin null animal (by33C), which 
showed the same suppression in the PTX induced seizure as tensinRNAi along 
with a defect in normal locomotion (Fig 3.5).  Finally, RNAi effects were validated 
by utilizing non-overlapping RNAi lines for tensin, βintegrin, talin, or FAK (Fig 
3.4C). 
The strength of suppression was not further enhanced by simultaneous 
expression of RNAi constructs for βintegrin and tensin (Fig 3.3C), which is 
consistent with these molecules functioning in the same genetic pathway.  These 
data indicate that astrocyte FA molecules modulate changes in neural 
excitation/inhibition balance at multiple developmental stages, and in response to 
both genetic and pharmacological induction of hyperexcitability.   
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Figure 3.3: Seizure induced by pharmacological blockade of GABA-A 
receptors are modulated by astrocyte focal adhesions  
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A, Raw traces of 3rd instar larval locomotion with and without picrotoxin treatment 
in control and RNAis for focal adhesion components.  Scale bars represent 1 cm.  
B, A distance traveled within one minute is measured to quantify locomotion 
speed for each RNAi.  Error bars represent SEM.  ****P<0.0001; two-way 
ANOVA and Tukey’s multiple comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 
18; alrmGAL4/+ (0.5 mg/ml PTX), N = 96; alrmGAL4/+ (1.5 mg/ml PTX), N = 66; 
alrmGAL4>UAS-tensin RNAi (0.0 mg/ml PTX), N = 15; alrmGAL4>UAS-tensin 
RNAi (0.5 mg/ml PTX), N = 33; alrmGAL4>UAS-tensin RNAi (1.5 mg/ml PTX), N 
= 24; alrmGAL4>UAS-βintegrin RNAi (0.0 mg/ml PTX), N = 4; alrmGAL4>UAS-
βintegrin RNAi (0.5 mg/ml PTX), N = 58; alrmGAL4>UAS-βintegrin RNAi (1.5 
mg/ml PTX), N = 45; alrmGAL4>UAS-talin RNAi (0.0 mg/ml PTX), N = 9; 
alrmGAL4>UAS-talin RNAi (0.5 mg/ml PTX), N = 55; alrmGAL4>UAS-talin RNAi 
(1.5 mg/ml PTX), N = 22; alrmGAL4>UAS-FAK RNAi (0.0 mg/ml PTX), N = 17; 
alrmGAL4>UAS-FAK RNAi (0.5 mg/ml PTX), N = 21; alrmGAL4>UAS-FAK RNAi 
(1.5 mg/ml PTX), N = 54 animals quantified.  C, Knockdown of βintegrin and 
tensin in astrocytes simultaneously had no additive effect on suppression 
phenotype.  Error bars represent SEM.  **P<0.005; two-way ANOVA and Tukey’s 
multiple comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 6; alrmGAL4/+ (1.5 
mg/ml PTX), N = 17; alrmGAL4>UAS-βintegrin RNAi; UAS-mCD8GFP (0.0 
mg/ml PTX), N = 12; alrmGAL4>UAS-βintegrin RNAi; UAS-mCD8GFP (1.5 
mg/ml PTX), N = 19; alrmGAL4>UAS-βintegrin RNAi; UAS-tensin RNAi (0.0 
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mg/ml PTX), N = 5; alrmGAL4>UAS-βintegrin RNAi; UAS-tensin RNAi (1.5 mg/ml 
PTX), N = 13 animals quantified. 
Full statistical details are provided in Table 3.   
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Astrocyte matrix metalloproteinase 1 (Mmp1) activity dynamically regulates 
seizure activity  
Matrix metalloproteinases (MMPs) are zinc-dependent endopeptidases that can 
degrade components of extracellular matrix (ECM), which then activate integrin 
signaling (Michaluk et al., 2009; Park and Goda, 2016)(Fig 3.2A).  Interestingly, 
increased neural activity or glutamate signaling has been found to elevate MMP 
activity and/or expression (Huntley, 2012; Nagy et al., 2006; Wilczynski et al., 
2008).  We explored the possibility that Drosophila MMPs might modulate 
nervous system excitability through FA signaling pathways using both loss- and 
gain-of-function approaches.  We first expressed RNAi lines targeting mmp1 in 
astrocytes in the easPC80 background and assayed sensitivity to bang-induced 
seizure.  We found depletion of mmp1 by RNAi suppressed hyperexcitability-
induced seizure behavior by decreasing recovery time (Fig 3.6A, A’).  
Reciprocally, astrocyte overexpression of MMP1 had the opposite effect and 
strongly enhanced seizure-like behavior (Fig 3.6A, A’).  We further found that 
Mmp1RNAi partially suppressed PTX-induced decreases in larval crawling 
behavior, (Fig 3.6B), and the same suppression was observed when PTX-treated 
animals were co-fed the MMP inhibitor, GM 6001 (Fig 3.6C).  We demonstrated 
that expressing UAS-Mmp1 RNAi under the control of the pan-neuronal driver 
elav-GAL4 resulted in no significant suppression of PTX-induced seizure 
behavior (Fig 3.7), arguing for an astrocyte-specific role for Mmp1.   
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Since MMPs are secreted as a pro-MMP form requiring extracellular 
activation to become enzymatically active form (Vandenbroucke and Libert, 
2014), the simplest model would be that Mmp1 activates integrin receptors 
extracellularly, which then signals through focal adhesion complex to modulate 
excitability.  To test this model we assayed for phenotypic interactions between 
Mmp1, βintegrin, and Talin in PTX-induced seizure assays.  We found addition of 
the MMP inhibitor did not enhance the rescuing effect of integrinRNAi, arguing 
Mmp1 and βintegrin are in the same genetic pathway in astrocyte regulation of 
excitability (Fig 3.8A).  Talin is a cytosolic adaptor protein and its expression is 
not required for the presence of integrins on the cell surface (Brown et al., 2002), 
we found the rescuing effect of talinRNAi in astrocytes was suppressed by Mmp1 
overexpression (Fig 3.8C).  Finally, we found that Mmp1 overexpression could 
not suppress the seizure suppression afforded by integrinRNAi (Fig 3.8B).  The 
simplest interpretation of these data is that Mmp1 exerts its effects through 
βintegrin-mediated FA signaling.  
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Figure 3.4: Confirmation of RNAi effects 
A, Relative food intake was comparable across genotypes.  Error bars represent 
SEM.  One-way ANOVA.  N = 3.  B, Expressing RNAi alone in astrocytes had no 
effect on PTX based behavioral assay.  Error bars represent SEM.  Two-way 
ANOVA and Tukey’s multiple comparisons.  W1118 (0.0 mg/ml PTX), N = 4; W1118 
(1.5 mg/ml PTX), N = 11; UAS-tensin RNAi /+ (0.0 mg/ml PTX), N = 13; UAS-
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tensin RNAi/+ (1.5 mg/ml PTX), N = 46; UAS-βintegrin RNAi /+ (0.0 mg/ml PTX), 
N = 11; N = 58; UAS-βintegrin RNAi/+ (1.5 mg/ml PTX), N = 46; UAS-talin 
RNAi/+ (0.0 mg/ml PTX), N = 10; UAS-talin RNAi/+ (1.5 mg/ml PTX), N = 16; 
UAS-FAK RNAi/+ (0.0 mg/ml PTX), N = 10; UAS-FAK RNAi/+ (1.5 mg/ml PTX), 
N = 37 animals quantified.  C, RNAi lines that are independent from the ones 
used in rest of the study displayed the same suppression effect on PTX assay.  
Error bars represent SEM.  ****P<0.0001; two-way ANOVA and Tukey’s multiple 
comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 15; alrmGAL4/+ (1.5 mg/ml 
PTX), N = 46; alrmGAL4>UAS-tensin RNAi (0.0 mg/ml PTX), N = 42; 
alrmGAL4>UAS-tensin RNAi (1.5 mg/ml PTX), N = 54; alrmGAL4>UAS-βintegrin 
RNAi (0.0 mg/ml PTX), N = 24; alrmGAL4>UAS-βintegrin RNAi (1.5 mg/ml PTX), 
N = 27; alrmGAL4>UAS-talin RNAi (0.0 mg/ml PTX), N = 32; alrmGAL4>UAS-
talin RNAi (1.5 mg/ml PTX), N = 46; alrmGAL4>UAS-FAK RNAi (0.0 mg/ml PTX), 
N = 25; alrmGAL4>UAS-FAK RNAi (1.5 mg/ml PTX), N = 35 animals quantified. 
Full statistical details are provided in Table 3. 
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Figure 3.5: tensin null, by33c phenocopies RNAi results 
tensin null animals (by33c) showed significant suppression in locomotion defect by 
PTX administration.  Error bars represent SEM.  ****P<0.0001; two-way ANOVA 
and Tukey’s multiple comparisons.  W1118 (0.0 mg/ml PTX), N = 17; W1118 (1.5 
mg/ml PTX), N = 20; by33c (0.0 mg/ml PTX), N = 21; by33c (1.5 mg/ml PTX), N = 
32 animals quantified.  Full statistical details are provided in Table 3. 
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Figure 3.6: Astrocyte matrix metalloproteinase 1 (MMP1) dynamically 
regulates seizure activity in genetic and pharmacological models 
A, Opposite effects of astrocyte MMP over-expression and knockdown on 
hyperexcitability induced behavior.  A’, Mean recovery time is measured based 
on data shown in A.  Error bars represent SEM.  ****P<0.0001; one-way ANOVA 
and Dunnett’s multiple comparisons.  N > 100 flies quantified for all genotypes.  
B, Genetically knocking down astrocyte Mmp1 suppressed PTX-induced 
locomotion defect.  Error bars represent SEM.  ****P<0.0001; two-way ANOVA 
and Tukey’s multiple comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 4; 
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alrmGAL4/+ (1.5 mg/ml PTX), N = 50; alrmGAL4>UAS-Mmp1 RNAi (0.0 mg/ml 
PTX), N = 15; alrmGAL4>UAS-Mmp1 RNAi (1.5 mg/ml PTX), N = 43 animals 
quantified.  C, Pharmacological inhibition of MMPs during PTX feeding showed 
locomotion defect suppression.  Error bars represent SEM.  *P<0.05; one-way 
ANOVA and Dunnett’s multiple comparisons.  W1118 (0.0 mg/ml PTX), N = 5; 
W1118 (0.0 mg/ml PTX, 50 µM inhibitor), N = 4; W1118 (1.5 mg/ml PTX), N = 19; 
W1118 (1.5 mg/ml PTX, 50 µM inhibitor), N = 19 animals quantified.  Full statistical 
details are provided in Table 3. 
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Figure 3.7: Neuronal knockdown of MMP1 has no effect on PTX-induced 
locomotion defect 
Genetically knocking down neuronal Mmp1 does not alter PTX-induced 
locomotion defect.  Error bars represent SEM.  Two-way ANOVA and Tukey’s 
multiple comparisons.  elavGAL4/+ (0.0 mg/ml PTX), N = 6; elavGAL4/+ (1.5 
mg/ml PTX), N = 15; elavGAL4>UAS-Mmp1 RNAi (0.0 mg/ml PTX), N = 6; 
elavGAL4>UAS-Mmp1 RNAi (1.5 mg/ml PTX), N = 12 animals quantified.  Full 
statistical details are provided in Table 3. 
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Figure 3.8: Matrix metalloproteinase1 (Mmp1) is a potential component of 
focal adhesion signaling pathway in astrocytes 
A, MMP inhibitor had no additive effect on βintegrin knockdown phenotype.  Error 
bars represent SEM.  *P<0.05; two-way ANOVA and Bonferroni’s multiple 
comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 7; alrmGAL4/+ (0.0 mg/ml PTX, 
50 µM inhibitor), N = 9; alrmGAL4/+ (1.5 mg/ml PTX), N = 14; alrmGAL4/+ (1.5 
mg/ml PTX, 50 µM inhibitor), N = 11; alrmGAL4>UAS-βintegrin RNAi (0.0 mg/ml 
PTX), N = 6; alrmGAL4>UAS-βintegrin RNAi (0.0 mg/ml PTX, 50 µM inhibitor), N 
= 8; alrmGAL4>UAS-βintegrin RNAi (1.5 mg/ml PTX), N = 15; alrmGAL4>UAS-
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βintegrin RNAi (1.5 mg/ml PTX, 50 µM inhibitor), N = 13 animals quantified.  B, 
The suppression level by βintegrin depletion in astrocytes in PTX assay had no 
change with overexpression of Mmp1.  Error bars represent SEM.  ****P<0.0001; 
two-way ANOVA and Dunnett’s multiple comparisons.  alrmGAL4/+ (0.0 mg/ml 
PTX), N = 12; alrmGAL4/+ (1.5 mg/ml PTX), N = 30; alrmGAL4>UAS-Mmp1 (0.0 
mg/ml PTX), N = 10; alrmGAL4>UAS-Mmp1 (1.5 mg/ml PTX), N = 12; 
alrmGAL4>UAS-βintegrin RNAi (0.0 mg/ml PTX), N = 18; alrmGAL4>UAS-
βintegrin RNAi (1.5 mg/ml PTX), N = 60; alrmGAL4>UAS-βintegrin RNAi; UAS-
Mmp1 (0.0 mg/ml PTX), N = 12; alrmGAL4>UAS-βintegrin RNAi; UAS-Mmp1 
(1.5 mg/ml PTX), N = 33 animals quantified.  C, Mmp1 over-expression in 
astrocytes reversed the effect of talin knockdown in PTX induced behavior.  Error 
bars represent SEM.  *P<0.05; two-way ANOVA and Bonferroni’s multiple 
comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 11; alrmGAL4/+ (1.5 mg/ml 
PTX), N = 7; alrmGAL4>UAS-mCD8GFP; UAS-talin RNAi (0.0 mg/ml PTX), N = 
11; alrmGAL4>UAS-mCD8GFP; UAS-talin RNAi (1.5 mg/ml PTX), N = 12 
animals quantified.  Full statistical details are provided in Table 3. 
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Focal adhesion signaling regulates astrocyte membrane coverage of the 
synaptic neuropil  
Focal adhesions serve critical roles in cell migration and tissue development and 
integrin mediated focal adhesion signaling in astrocytes is known to govern 
astrocyte cell spreading and morphology in vitro (Kong et al., 2013; Leyton et al., 
2001).  To determine whether our manipulations of astrocyte FA molecules 
altered astrocyte morphology, we examined astrocyte processes in the CNS by 
transmission electron microscopy.  We prepared 3rd instar larval brains from 
control and βintegrinRNAi animals, and focused our analysis on ventral nerve cord 
where astrocyte morphology has been well-described (Stork et al., 2014).  
Astrocyte processes were identified by their electron-dense cytoplasm.  
Compared to controls, astrocyte βintegrinRNAi animals exhibited a reduction in the 
total area covered by the processes under normal physiological conditions (Fig 
3.9A, B).  Consistent with our observations by light microscopy and Western 
blots (data performed by Allie Muthukumar not presented here), we found no 
change in the number of synapses in βintegrinRNAi animals compared to controls 
(Fig 3.9D).  Thus, βintegrin is essential for the establishment of normal coverage 
of the synaptic neuropil by fine astrocyte processes.  
We next sought to explore how FA molecules like βintegrin would regulate 
astrocyte membrane responses to hyperexcitability.  While exposure of control 
animals to PTX did not change astrocyte coverage of the synaptic neuropil, 
astrocyte βintegrinRNAi animals exhibited a marked increase in neuropil coverage 
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by astrocyte profiles and a decrease in the distance between astrocyte 
membranes and synapses (Fig 3.9A, B, C), and this was in the absence of 
changes in the total number of synapses in the neuropil (Fig 3.9A, D). 
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Figure 3.9: Focal adhesions regulate astrocyte morphology and synapse 
coverage 
A, Ultrastructure of neuropil area from Drosophila 3rd instar ventral nerve cord by 
transmission electron microscopy.  Putative astrocyte processes are pseudo 
colored in yellow.  Three different animals were analyzed for each group.  B, 
Quantification of percent area covered by astrocyte processes.   C, Quantification 
of the distance from a synapse to the nearest astrocyte process.  D, 
A    B
   C
   D
Wilde type 
Wilde type 
integrin RNAi 
C
on
tro
l f
oo
d 
P
TX
 fo
od
 
* 
* 
**** 
*** ** 
** 
 68 
Quantification of number of synapses.  Error bars represent SEM.  *P<0.05, 
**P<0.005, ***P<0.001, ****P<0.0001; two-way ANOVA and Tukey’s multiple 
comparisons.  18 VNC sections from three different animals were quantified for 
each group. 
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Astrocyte focal adhesion signaling regulates levels of the excitatory amino 
acid transporter EAAT1  
In addition to changes in astrocyte coverage of the synaptic neuropil, changes in 
excitatory or inhibitory neurotransmitter transporters on astrocytes could also 
significantly impact physiological responses to hyperexcitability.  Consistent with 
previous studies in the adult brain, EAAT1 showed prevalent expression in 
astrocytes in ventral nerve cord of 3rd instar larvae (Fig 3.10A).  Astrocyte-
specific knockdown of EAAT1 significantly impaired larval locomotion, which 
implies astrocytic EAAT1 plays an important role in regulating glutamate 
transmission that is required for proper movement of the animal (Fig 3.10C).  The 
above observations prompted us to investigate the possibility of changes in 
astrocytic EAAT1 as a potential mechanism for the suppression behavior in PTX-
induced locomotion defect in focal adhesion molecule knockdowns.   
We found that depletion of either βintegrin or Tensin from astrocytes by 
RNAi resulted in a decrease in EAAT1, the sole high-affinity glutamate 
transporter in Drosophila (Besson et al., 2000), under normal physiological 
conditions (Fig 3.11A, B).  In contrast, Western blot analysis revealed that 
astrocytic GABA transporter (Gat) levels were not altered when we compared 
astrocyte tensinRNAi animals to controls (data performed by Allie Muthukumar not 
presented here).  These are consistent with our findings above that FA molecules 
are required in astrocytes to promote normal coverage of the synaptic neuropil by 
fine processes of astrocytes.  Surprisingly, we found that treatment of animals 
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with picrotoxin to induce seizure had the opposite effect:  it led to a roughly 2-fold 
increase in EAAT1 levels in both astrocyte βintegrinRNAi and tensinRNAi animals 
(Fig 3.11A, C).  This observation indicates that FA regulation of EAAT1 is 
different under normal physiological conditions compared to hyperexcitability, 
and implies that increases in EAAT1 levels may be responsible for the 
suppression of seizure activity we see in these animals.  Consistent with this 
interpretation, we found that feeding larvae the EAAT1 inhibitor DHK suppressed 
the ability of βintegrinRNAi or tensinRNAi to rescue animals from seizure-induced 
immobility while the administration of DHK alone did not affect the locomotion 
behavior (Fig 3.10B and Fig 3.12A).  Likewise, application of dihydrokainic acid 
(DHK) blocked the ability of mmp1RNAi to suppress seizure phenotypes in larval 
crawling (Fig 3.12B).  Overexpression of EAAT1 in astrocytes was not able to 
phenocopy the effect of the focal adhesion knockdowns in the PTX assay (Fig 
3.13), which suggests there might be differences between acute versus chronic 
upregulation of EAAT1.  Overall, these data argue that under normal conditions 
FA molecules are required to establish appropriate levels of EAAT1 on astrocyte 
membranes, but under conditions of hyperexcitability, FAs negatively regulate 
EAAT1 expression, and their depletion allows for a more robust increase in 
astrocyte EAAT1 and rescue of seizure-like behavior. 
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Figure 3.10: Glutamate transporter, EAAT1 function in astrocytes 
A, EAAT1-GAL4 driver with UAS-mCD8GFP to show the localization of EAAT1 in 
astrocytes.  EAAT1 expressing cells are labeled with membrane tethered GFP 
and astrocyte membrane is labeled by α-Gat antibody.  B. Locomotion speed 
quantification from larvae fed either with vehicle or 500 µM DHK.  Error bars 
represent SEM.  Unpaired t test.  W1118 (0.0 µM inhibitor), N = 11; W1118 (500 µM 
inhibitor), N = 29 animals quantified.  C, Larval locomotion was impaired when 
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EAAT1 was depleted in astrocytes.  Error bars represent SEM.  ****P<0.0001; 
unpaired t test.  alrmGAL4/+, N = 16; alrmGAL4>UAS-Eaat1 RNAi, N = 9 
animals quantified.   
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Figure 3.11: Astrocyte focal adhesion signaling regulates levels of the 
excitatory amino acid transporter EAAT1 
A, Western blot analysis on 3rd instar larval CNS lysates probed with anti-EAAT1.  
B, Quantification of Eaat1 levels in western blot normalized to Tubulin signal and 
to the control lane (N = 6).  Error bars represent SEM.  **P<0.005, ****<P0.0001; 
one-way ANOVA and Dunnett’s multiple comparisons.  C, Quantification of Eaat1 
Tubulin 
Eaat1 
A
C
B
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Control 1.5 mg/ml PTX
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levels in western blot normalized to Tubulin signal and to the control lane (N ≥ 6).  
Error bars represent SEM.  **P<0.005, ***<P0.001; Unpaired t test. 
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Figure 3.12: Glutamate transporter inhibitor reverses the behavioral effect 
of astrocyte depletion of focal adhesion genes or Mmp1   
A, Pharmacological inhibition of EAAT function blocked βintegrin or tensin 
knockdown effect on PTX induced locomotion behavior.  Dihydrokainic acid 
(DHK) was applied along with PTX and feeding period was 9 hr.  Error bars 
represent SEM.  ****P<0.0001; two-way ANOVA and Tukey’s multiple 
comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 13; alrmGAL4/+ (1.5 mg/ml 
PTX), N = 25; alrmGAL4/+ (1.5 mg/ml PTX, 500 µM inhibitor), N = 16; 
alrmGAL4>UAS-βintegrin RNAi (0.0 mg/ml PTX), N = 12; alrmGAL4>UAS-
B
A
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βintegrin RNAi (1.5 mg/ml PTX), N = 25; alrmGAL4>UAS-βintegrin RNAi (1.5 
mg/ml PTX, 500 µM inhibitor), N = 18; alrmGAL4>UAS-tensin RNAi (0.0 mg/ml 
PTX), N = 8; alrmGAL4>UAS-tensin RNAi (1.5 mg/ml PTX), N = 17; 
alrmGAL4>UAS-tensin RNAi (1.5 mg/ml PTX, 500 µM inhibitor), N = 10 animals 
quantified.  B, EAAT inhibitor also prevented suppression of PTX induced 
locomotion defect by astrocyte specific knockdown of Mmp1.  Error bars 
represent SEM.  *P<0.05; two-way ANOVA and Bonferroni’s multiple 
comparisons.  alrmGAL4/+ (0.0 mg/ml PTX), N = 8; alrmGAL4/+ (1.5 mg/ml 
PTX), N = 18; alrmGAL4/+ (1.5 mg/ml PTX, 500 µM inhibitor), N = 20; 
alrmGAL4>UAS-Mmp1 RNAi (0.0 mg/ml PTX), N = 10; alrmGAL4>UAS-Mmp1 
RNAi (1.5 mg/ml PTX), N = 21; alrmGAL4>UAS-Mmp1 RNAi (1.5 mg/ml PTX, 
500 µM inhibitor), N = 28 animals quantified.  Full statistical details are provided 
in Table 3. 
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Figure 3.13: Genetic overexpression of Eaat1 in astrocytes affects normal 
locomotion and fails to suppress locomotion defect by PTX administration 
Overexpression of EAAT1 in astrocytes altered normal locomotion and did not 
suppress PTX-induced locomotion defect.  Error bars represent SEM.  
**P<0.005; two-way ANOVA and Tukey’s multiple comparisons.  alrmGAL4/+ 
(0.0 mg/ml PTX), N = 10; alrmGAL4/+ (1.5 mg/ml PTX), N = 19; alrmGAL4>UAS-
Eaat1 (0.0 mg/ml PTX), N = 6; alrmGAL4>UAS-Eaat1 (1.5 mg/ml PTX), N = 5 
animals quantified.  Full statistical details are provided in Table 3. 
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Figure 3.14: Working model 
A model suggesting how focal adhesions in astrocytes might modulate 
glutamatergic synapses to regulate the balance between excitation and inhibition 
by altering their morphologies and EAAT1 expression during network 
hyperexcitability.  A, Our data suggest that Mmp1 works upstream of the focal 
adhesion signaling in astrocytes to regulate seizure-like behavior that is induced 
genetically or pharmacologically.  B, blockade of focal adhesion signaling in 
E I E I 
Wild-type astrocyte FA signaling attenuated astrocyte 
Glutamatergic synapse C
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astrocytes at basal levels of CNS excitability resulted in reduced astrocytic 
coverage of the neuropil and reduced expression of the excitatory amino acid 
transporter EAAT1.  C, induction of hyperexcitability after depletion of focal 
adhesion signaling components resulted in enhanced astrocyte coverage of the 
neuropil and significant increase in EAAT1 levels, which might directly affect 
excitatory glutamatergic synapses to show the suppression of seizure-like 
behavior. 
 
Discussion 
We provide multiple lines of evidence that FA molecules regulate seizure 
behavior in vivo.  Astrocyte-specific depletion of FA signaling molecules led to 
significant suppression of seizure behavior in the bang-sensitive model of 
hyperexcitability in adults and picrotoxin-induced hyperexcitability in larvae.  A 
deeper analysis of astrocyte markers and morphology revealed that blockade of 
FA signaling under normal physiological conditions led to reduced coverage of 
the neuropil by astrocytes’ fine processes and reduced levels of EAAT1 
expression.  This modulatory effect of FAs appears to be specific to EAAT1, as 
levels of the sole Drosophila GABA transporter GAT appeared unchanged in FA 
knockdown animals.  These findings are consistent with a mammalian study 
showing astrocyte knockout of β1integrin leads to impaired glutamate uptake by 
astrocytes with decreased GLT-1 levels resulting in reactive astrogliosis and 
spontaneous seizures (Robel et al., 2015).  However, decreased levels of EAAT1 
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by βintegrin or tensin knockdowns displayed normal locomotion, while EAAT1 
depletion in astrocytes by RNAi caused significant defect in crawling behavior 
(Fig 3.3B, Fig 3.10C).  There might be a delayed effect on changes in EAAT1 
levels by focal adhesion knockdowns, which enables animals to bypass 
developmental defects.  In fact, GLT-1 downregulation started to appear when 
β1integrin knockout mice were 6 months old (Robel et al., 2015).  Nevertheless, 
our data suggest under normal physiological conditions FAs promote expression 
of EAAT1 in astrocytes and normal astrocyte coverage of the neuropil.  
Under conditions of hyperexcitability FAs appear to negatively regulate EAAT1 
expression and astrocyte infiltration of the neuropil.  FA knockdown increased 
EAAT1 levels ~2-fold and led to greater coverage of the neuropil by astrocyte 
processes.  EAAT1 does not appear to be regulated directly by picrotoxin-
induced hyperexcitability, as picrotoxin exposure alone did not alter EAAT1 
levels.  We suspect that the simultaneous increase of astrocytic coverage of 
synapses and EAAT1 together underlie the enhanced recovery from seizure 
behavior.  For instance, overexpression of EAAT1 alone did not block the ability 
of picrotoxin to induce seizure behavior (Fig 3.13).  Therefore increased EAAT1 
in astrocytes alone is not sufficient to account for the phenotypic rescue we 
observe in FA knockdown animals.  EAAT1 function is certainly important for 
modulating seizure activity; given that blockade of EAAT1 with the inhibitor DHK 
suppressed the rescuing effects of astrocytic FA knockdown on seizure-like 
behavior.  In mammals, alteration of GLT-1 alone was sufficient promote 
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changes in long-term synaptic plasticity, but not basal synaptic activity (Filosa et 
al., 2009; Omrani et al., 2009).  Interestingly, under conditions where there was a 
simultaneous increase in EAAT and astrocyte synaptic coverage, significant 
changes in basal synaptic activity were observed (Pannasch et al., 2014).  
Moreover, astrocyte coverage was modulated by changes in cell adhesion 
(Pannasch et al., 2014).  We suspect the combined effect of increased EAAT1 
with closer association with synapses leads to the suppression of seizure we 
observe, and that this is likely due to enhanced clearance of extracellular 
glutamate. 
Precisely how FAs modulate astrocyte process extension and EAAT1 
expression is an important next question.  It is possible that activation of EAAT1 
expression and genes required for astrocyte growth are downstream of FA 
activation.  FAK is certainly a well-known regulator of transcriptional activity 
(Parsons, 2003).  It is also possible that the decreased adhesive properties of 
cells in which FA signaling molecules have been depleted can respond more 
dynamically with process extension in response to pathological changes in 
neuronal activity.  Connexin30 is a key modulator of cell adhesion in astrocytes 
and is required for astrocyte process extension (Pannasch et al., 2014), but 
whether this is regulated by FAs or neuronal activity remains an open question.   
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Materials and Methods 
Fly strains.  The following Drosophila strains were used: w1118 Canton S, alrm-
GAL4 (Doherty et al., 2009), Eaat1-GAL4 (Doherty et al., 2009), UAS-
mCD8::GFP (Lee et al., 1999), easPC80 (Pavlidis et al., 1994), by33c (Torgler et al., 
2004), tensin-GFP (Torgler et al., 2004). 
The following UAS-RNAi lines were from Vienna Drosophila Resource Center 
(Vienna, Austria): UAS-byRNAi#22823, UAS-mysRNAi#103704, UAS-rheaRNAi#40399, 
UAS-FAKRNAi#108608.  The following lines were from Bloomington Drosophila 
Stock Center (Bloomington, IN): UAS-Mmp1#58700, UAS-Mmp1RNAi#31489, UAS-
Mmp2RNAi#31371, UAS-byRNAi#38288, UAS-mysRNAi#33642, UAS-rheaRNAi#33913, 
UAS-FAKRNAi#29323. 
 
Immunohistochemistry and confocal microscopy.  Drosophila larval CNSs 
were dissected in PBS and fixed for 25 min at room temperature.  4 % 
paraformaldehyde was used for a routine fixation and Bouin’s fixative was used 
to prepare samples for anti-Eaat1 immunohistochemistry.  The following primary 
antibodies were used: rabbit anti-Eaat1 ((Peco et al., 2016)1:4000), rabbit anti-
Gat ((Stork et al., 2014)1:2000), mouse anti-Bruchpilot (Developmental Studies 
Hybridoma Bank: nc82,1:20), mouse anti-Repo (Developmental Studies 
Hybridoma Bank: 8D12, 1:10), mouse anti-myospheroid (Developmental Studies 
Hybridoma Bank: CF.6G11, 1:50). 
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Immunoblotting.  Drosophila CNSs were dissected in PBS and homogenized in 
SDS loading buffer (60 mM Tris pH 6.8, 10% glycerol, 2% SDS, 1% β-
mercaptoethanol, 0.01% bromophenol blue).  Samples were centrifuged at 
16,000g for 10 min at 4 °C to collect supernatants. After boiling at 95 °C for 5 
min, each samples were run on SDS-PAGE gels and transferred to nitrocellulose 
membranes.  Appropriate primary antibody was diluted in blocking buffer (5% 
non-fat dry milk, 0.01 % Tween 20 in PBS) to incubate membranes overnight at 4 
°C. Following with three 10-min washes, membranes were incubated with 
appropriate HRP-conjugated secondary antibody at room temperature for 1 hr.  
Chemiluminescence detection (ECL Plus Amersham) system was used to image 
signal with Fujifilm Luminescent Image Analyzer LAS-4000.  Blots were analyzed 
using ImageJ Software.  The following antibodies were used: 1:8,000 rabbit anti-
Eaat1 (Peco et al., 2016); 1:10,000 rabbit anti-Gat (Stork et al., 2014); 1:50,000 
mouse anti-tubulin (Sigma T9026); 1:6,000 sheep HRP-conjugated anti–mouse 
IgG (Abcam ab6808); 1:6,000 goat HRP-conjugated anti-rabbit IgG (Abcam 
ab6721). 
 
Bang-sensitive behavioral assay.  The behavioral assay was modified from 
Song et al. (2008) and described in Muthukumar et al. (2014).  Adult male flies 
after 3-7 days of eclosion were collected in fresh food vials the night before 
experiments.  Vials containing 10 – 15 flies were subjected to mechanical 
stimulus using a VWR Vortex Mixer (VWR International, West Chester, PA) at a 
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maximum speed for 10 sec to induce paralysis and seizure in bang-sensitive 
mutant, easPC80.  The numbers of flies standing and resuming normal behavior 
was noted at 10 s intervals for 4 min.  Mean recovery time was calculated as the 
average time taken by an individual fly to recover from paralysis. 
 
Picrotoxin feeding.  Picrotoxin was dissolved in acetone and added to 
microwaved standard cornmeal agar to mix and make final concentrations of 0.5 
and 1.5 mg/ml.  Broad spectrum MMP inhibitor, GM6001 and EAAT2 (GLT-1) 
inhibitor, dihydrokainic acid were each prepared in DMSO and water respectively 
to mix in with food.  The food with appropriate drugs was prepared the night 
before experiments.  Early third instar larvae were collected to place in prepared 
drug containing food and 9 hr of feeding was allowed. 
 
Larval locomotion behavior.  Locomotion behavior was analyzed using FTIR-
based Imaging Method (FIM) (Risse et al., 2013).  Third instar larvae were 
collected and washed gently with water before placed on arena made of 0.8 % 
agar.  Larval behavior was filmed with 10 frames per second for one minute.  
Crawling trajectory was analyzed with FIMTrack Software and the speed of 
locomotion was quantified using NeuronJ, ImageJ plugin. 
 
Transmission electron microscopy.  Experiments were conducted at the 
University of Massachusetts Medical School Electron Microscopy core facility.  
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For each condition, at least three animals were prepared for TEM procedure and 
analysis.  Larval CNSs were dissected in PBS and immediately fixed in 2.5% 
gluteraldehyde in 0.1 M Sodium Cacodylate buffer pH 7.2. Briefly, fixed samples 
were moved into fresh 2.5% gluteraldehyde in 0.1 M Sodium Cacodylate buffer 
and left overnight at 4oC.  The samples were then rinsed twice in the same 
fixation buffer and post-fixed with 1% osmium tetroxide for 1h at room 
temperature.  Samples were then washed twice with DH2O for 5 minutes and 
then dehydrated through a graded ethanol series of 20% increments, before two 
changes in 100% ethanol.  Samples were then infiltrated first with two changes of 
100% Propylene Oxide and then with a 50%/50% propylene oxide / SPI-Pon 812 
resin mixture.  The following day three changes of fresh 100% SPI-Pon 812 resin 
were done before the samples were polymerized at 68oC in plastic capsules.  
The samples were then reoriented, and thin sections were taken at 
approximately 100 microns from the posterior tip of the ventral nerve cord.  The 
thin sections (approx. 70 nm) were placed on copper support grids, and 
contrasted with Lead citrate and Uranyl acetate.  Sections were examined using 
the FEI Tecani 12 BT with 100Kv accelerating voltage, and images were 
captured using a Gatan TEM CCD camera. 
 
Statistical analysis.  Graphpad Prism software was used to perform statistical 
analysis.  Two-tailed Student’s t-test or two-way ANOVA with either Dunnett’s or 
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Tukey’s post hoc test was performed and P < 0.05 was considered significant.  
Error bars in bar graphs indicate SEM.  
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CHAPTER 4: Discussion 
Astrocyte processes infiltrate all synapse-rich regions of the brains of complex 
metazoans and are poised to globally regulate synaptic activity.  In this study we 
explored how astrocyte-expressed molecules regulate nervous system 
physiology in response to neuronal hyperactivation, using genetic and 
pharmacological models of seizure in Drosophila.  We found that astrocyte 
depletion of focal adhesion (FA) molecules strongly suppressed seizure-like 
behavior at both larval and adult stages.  Astrocyte depletion of Mmp-1, a matrix 
metalloproteinase known to regulate β-integrin activation, also suppressed 
seizure activity, while overexpression of Mmp-1 had the opposite effect and 
enhanced seizures.  Blockade of FA signaling under normal physiological 
conditions led to decreased coverage of the neuropil by astrocyte processes and 
reduced expression of EAAT1.  However, upon induction of neuronal 
hyperactivity, depletion of FAs led to enhanced coverage of the neuropil by 
astrocyte processes and a 2-fold increase in EAAT1.  Given that the rescuing 
effect of FA depletion after seizure was suppressed by pharmacological blockade 
of EAAT1, we propose the elevated levels of EAAT1 in FA knockdown animals, 
together with enhanced astrocyte coverage of the neuropil, is responsible for the 
behavioral rescue in seizure assays.   
 
Astrocyte focal adhesion signaling during periods of hyperexcitability 
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Based on our RNAi screen in Drosophila adults with a mutation causing 
hyperexcitability induced seizure-like behavior, Tensin, an adaptor protein in a 
focal adhesion complex emerged as a candidate to suppress seizure when 
knocked down in astrocytes (Fig 3.1A).  To confirm the specificity of the 
behavioral effect by tensin RNAi, a second RNAi line was tested and resulted in 
similar suppression (Fig 3.1A).  When RNAi-mediated tensin knockdown 
efficiency in astrocytes was analyzed under confocal microscopy, we observed 
about a 40 % decrease in tensin level compared to control (Fig3.1B,B’).  We 
suspect the actual efficiency of RNAi knockdown might be greater because we 
focused on the quantification of Tensin-GFP that fell within the domains of anti-
Gat immunoreactivity, which only labels the membrane.  In fact, when we 
express tensin RNAi under the control of tubulin-GAL4, a distinct pattern of 
tensin::GFP punctae was not detectable (Fig 3.1C). 
 Other components of focal adhesions including βintegrin, talin, and FAK 
phenocopied the behavioral effect by tensinRNAi suggesting astrocyte focal 
adhesion signaling plays an important role in regulating hyperexcitability induced 
behavior (Fig 3.2).  Characterization of seizure behavior induced by picrotoxin 
(PTX) in 3rd instar larvae corroborates the effect of astrocyte specific knockdown 
of FA molecules in the context of general network hyperexcitability (Fig 3.3A, B). 
Finally, the strength of suppression was not further enhanced by simultaneous 
expression of RNAi for β-integrin and tensin suggesting these molecules might 
function in the same genetic pathway.  Though we would lose cell-type specificity 
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in that manipulation, in the future we could test if astrocyte depletion of βintegrin 
in tensin null mutant backgrounds had an additional suppression compared to 
βintegrinRNAi alone. 
 Studies in rodents with conditional knock-out of β1integrin in ependymal 
zone stem cells have shown increased expression of Glial fibrillary acidic protein 
(GFAP) and astrocytic differentiation without altering oligodendrocyte or neuronal 
differentiation (North et al., 2015), which argues a somewhat specific role for 
integrin signaling in astrocytes rather than other glia.  Indeed, another study 
found more direct linkage between integrin and astrocyte function in regulation of 
neuronal network (Robel et al., 2015).  Using a GFAP-cre line, researchers 
knocked out β1integrin in astrocytes to induce astrogliosis and then investigated 
the effect of activated astrocytes on spontaneous seizure.  While the genetic 
deletion of β1integrin was not entirely astrocyte-specific, the authors showed a 
strong correlation between the conditional knockout of β1integrin and 
development of seizure by neuronal hyperexcitability (Robel et al., 2015).  
Although we see no evidence that βintegrin depletion leads to reactive gliosis in 
Drosophila astrocytes, our data along with mammalian studies provide a strong 
argument that integrin associated focal adhesion in astrocytes plays an important 
role in a context of seizure and hyperexcitability. 
 
How might focal adhesions signal in astrocytes? 
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Focal adhesions are macromolecular complexes at the cell-matrix interface to 
link actin-containing microfilaments and extracellular environment (Hotulainen, 
2006).  They change assembly and turnover rates rapidly in response to 
environmental cues, including gradients of chemokines, growth factors, or 
extracellular matrix (ECM) molecules to adapt cell shape and function (Le 
Clainche and Carlier, 2008; Lele et al., 2008; Lin et al., 1994; Lo, 2006; Ridley et 
al., 2003). 
Adhesion is mediated by transmembrane receptors called integrins, a 
family of heterodimeric proteins consisting of α- and β-integrins. Upon integrin 
receptor activation, actin binding proteins, also known as adaptor proteins such 
as vinculin, talin, and tensin, are recruited to form adhesions and tightly link to 
control actin assembly and disassembly (Le Clainche and Carlier, 2008; Lin et 
al., 1994).  Dynamic structural reorganization or remodeling of actin filaments 
governs a variety of cellular processes, such as cell motility, membrane 
dynamics, cell cycle control, cellular structure and cell signaling in various cell 
types including astrocytes (Farwell et al., 1995; Nicchia et al., 2008; Oberheim et 
al., 2008; Siegrist-Kaiser et al., 1990; Zhu, 2005). 
 Actin is a major cytoskeletal component that is essential to maintain and 
sculpt cell shape, and dynamic changes of actin cytoskeleton drive a variety of 
processes such as cell motility, cell division, and intracellular protein trafficking.  
Because of their dynamic nature, actin molecules in dendritic spines are 
intensively studied in the context of spine morphology and synaptic plasticity.  In 
 93 
addition to their functions in morphological changes, actins also play a critical 
role in providing a scaffold for neurotransmitter receptors and facilitating the 
trafficking of synaptic machinery (Cingolani and Goda, 2008).  Actins are 
enriched in astrocytes, especially in distal fine processes, where they can 
mediate rapid shape changes (Lau et al., 2011; Lavialle et al., 2011; Stork et al., 
2014).  Do changes in activity alter actin dynamics and in turn morphology of 
astrocytes?  In vitro studies have shown that treatment with the excitatory 
neurotransmitter glutamate can induce filopodia formation in astrocytes and 
increase actin cytoskeleton-based motility (Cornell-Bell et al., 1990; Lavialle et 
al., 2011).  Long-term potentiation in the hippocampus significantly changed the 
ramification of astrocyte processes by increasing surface area (Wenzel et al., 
1991) and an in vivo study shows motor skill learning induces an increase in 
astrocytic volume in the cerebellar cortex (Kleim et al., 2007).  Given that focal 
adhesions provide a direct link between the extracellular space and actin, I 
propose that changes in the actin cytoskeleton downstream of focal adhesion 
signaling drives morphological changes of astrocytes, which in turn modify their 
physiological interactions with synpases (e.g. increased Glu buffering).  The 
dynamic nature of actin cytoskeleton is also associated with changes in the 
surface exposure of membrane proteins.  In a variety of settings, reorganization 
of actin cytoskeleton increases membrane protein expression and trafficking to 
the surface (Chen et al., 2013; Gu et al., 2010; Lau et al., 2011).  For instance, 
actin remodeling in cultured astrocytes by the Rho kinase inhibitor increases 
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astrocyte glutamate transporter (EAAT1 and EAAT2) levels and activity (Lau et 
al., 2011).  Since changes of neurotransmitter transporter levels in astrocyte 
membranes directly shape synaptic activities (Murphy-Royal et al., 2015; 
Muthukumar et al., 2014), this implies changes in astrocyte morphology could 
have a strong association with astrocytic regulation of synapses.  Finally, since 
integrin-mediated focal adhesions have diverse signaling functions based on 
their molecular components and cellular context, especially during development 
of the nervous system and synaptogenesis, activation of glia, or stabilization of 
the endothelium and blood-brain barrier (Milner and Campbell, 2002), our 
findings opens up a number of avenues for exploration to define the precise 
mechanisms by which FAs alter animal responses to hyperexcitability. 
 
MMP as a potential activator of FA signaling in astrocytes 
Integrins, heterodimeric cell surface receptors from focal adhesion complexes, 
receive signaling from the extracellular matrix (ECM).  ECMs are the substrates 
for the matrix metalloproteinases (MMPs), extracellular zinc-dependent 
endopeptidases and their enzymatic activity leads to the cleavage of ECM 
proteins which then activate integrin signaling (Lukashev and Werb, 1998; Werb, 
1997).  
Interestingly, there is a strong correlation between neuronal activity and 
MMP expression and/or activity.  Under normal physiological conditions, the 
expression of MMP9 in particular has been reported to be essential to form 
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neuronal activity-dependent plasticity in rodent cortices as well as hippocampus 
(Kaliszewska et al., 2012; Nagy et al., 2006; Spolidoro et al., 2011).  In addition, 
increased expression and enzymatic activity of MMPs are known to be a critical 
element in the development of seizure and cocaine relapse and relapse-
associated synaptic plasticity (Smith et al., 2014; Wilczynski et al., 2008).  Finally 
it has been suggested that chronic elevation of network activity can increase 
activation of MMPs (Huntley, 2012).  These observations argue that increased 
activity leads to increased MMP signaling, which could in turn regulate integrin 
receptor-mediated focal adhesion signaling in astrocytes in a hyperexcitable 
network.  Consistent with this interpretation, by depleting Mmp1 expression in 
astrocytes, we were able to observe the same suppression effect as focal 
adhesion knockdowns on both genetically and pharmacologically induced seizure 
assays (Fig 3.6).  When we conversely overexpressed astrocyte Mmp1, 
enhancement of seizure phenotype was observed in the genetic seizure model 
(Fig 3.6A, A’).  These data provide a strong in vivo link between the level of MMP 
expression and animal responses to hyperexcitability.  Based on the preliminary 
data from the Freeman lab comparing translating mRNA transcripts between 
neurons and astrocytes using a technique called Translating Ribosome Affinity 
Purification (TRAP), Mmp1 mRNA showed 7-fold enrichment in astrocytes 
compared to neurons in 3rd instar larval brains.  Thus, astrocytes appear to be 
the major Mmp1 expressing cell type in the CNS and attempting to deplete 
Mmp1 from a minor source of the protein might have resulted in insufficient 
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knockdown.  This hypothesis is also supported by the fact that the degree of 
suppression we observed with pharmacological inhibitor of MMP in the PTX 
assay (Fig 3.6C) was comparable with the result from the expression of Mmp1 
RNAi in astrocytes (Fig 3.6B).  From our assays for phenotypic interactions 
between Mmp1 and focal adhesion molecules in PTX-induced seizure-like 
behavior, we found that addition of the MMP inhibitor had no enhanced rescuing 
effect on animals expressing βintegrin RNAi suggesting Mmp1 and βintegrin 
work in the same genetic pathway in astrocytes to regulate this behavior (Fig 
3.8A).  Further pathway analysis utilizing genetic overexpression of Mmp1 in 
astrocytes with integrin receptor knockdown showed that Mmp1 may exert its 
effects through βintegrin-mediated focal adhesion signaling to regulate 
hyperexcitability induced behavior (Fig 3.8B).  The simplest interpretation is that 
Mmp1 is secreted by astrocytes, where it acts outside the cells—it is secreted as 
a pro-MMP form and requires extracellular activation to become enzymatically 
active (Vandenbroucke and Libert, 2014)—to break down ECM and activate FA 
signaling.  Consistent with this notion Mmp1 overexpression was able to reverse 
the effect of talin RNAi in the same behavioral assay, but not that of the receptor 
knockdown.  One possible explanation is that expression of talin is not absolutely 
required for integrin expression and signaling (Brown et al., 2002; Conti et al., 
2009; Liu et al., 2011).  Thus, even with significant depletion of expression of 
talin in astrocytes, increased Mmp1 may overcome this loss due to redundancy 
with other FA molecules, or partial Talin knockdown, while loss of the βintegrin 
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receptor cannot be overcome because it is absolutely essential for Mmp1 to exert 
its effects. 
 A number of questions remain regarding the interactions between MMPs 
and the focal adhesion signaling in a context of hyperexcitability.  First, is there 
elevated expression or activity of Mmp1 in response to PTX treatment?  Oral 
consumption of PTX induces a global stimulation of neuronal activity resulting in 
seizure in Drosophila 3rd instar larvae (Stilwell et al., 2006).  Electrophysiological 
recordings on body wall muscles of larval preparations with preserved CNS 
showed seizure activity with PTX application.  The PTX effect was abolished 
when motor neurons are severed from the nerve cord, suggesting PTX affects 
the excitability in the CNS to elicit seizure-like behavior (Stilwell et al., 2006).  
Thus, our method to induce network hyperexcitability is likely robust.  In rodents, 
astrocytes constitutively express MMPs in vitro as well as in vivo and their 
expression becomes upregulated when synaptic activity is heightened with 
administration of kainate, an agonist for non-NMDA glutamate ionotropic 
receptors (Szklarczyk et al., 2002).  Therefore we hypothesize there is elevated 
expression and/or activity of Mmp1 with PTX administration in Drosophila 3rd 
instar larvae which leads to increased βintegrin signaling as MMPs degrade 
extracellular matrix that are ligands for integrin receptors.  Based on previous 
reports, we would speculate that the time course of MMP activation and 
termination would be relatively fast (1 – 2 hours after intense stimulation) 
(Huntley, 2012; Nagy et al., 2006).  An experiment where one examined the time 
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course of Mmp1 activation after PTX feeding will be required to determine the 
precise effects.    
 The primary source of MMPs (which we propose is astrocytes) and their 
mechanism of activation is another important area requiring clarification.  MMPs 
can be activated by each other (Huntley, 2012) or free radicals like nitric oxide 
(NO) (Huntley, 2012).  Increased synaptic stimuli such as long-term potentiation 
activates postsynaptic NMDA receptor upon presynaptic glutamate release which 
in turn triggers rapid release of nitric oxide (NO) into the perisynaptic 
environment (Huntley, 2012; Schuman and Madison, 1991).  In the future it will 
be important to find the source that kindles the initial activation of MMPs to 
determine more efficient ways to regulate focal adhesion signaling in vivo. 
 Finally, what is the mechanism of integrin receptor activation by Mmp1?  
Is it through a specific ECM protein that is enzymatically processed by Mmp1?  
Or is it a direct action of Mmp1 on integrins?  Degradation of ECM by MMPs 
activates integrin receptors (Stefanidakis and Koivunen, 2006; Werb, 1997).  
Studies have also shown direct enzymatic action of MMPs on integrin receptors, 
integrin β1 itself is shown to be a substrate for MMP2 (Kryczka et al., 2012).  
Thus, both direct and indirect effects of MMP activity on integrin receptors could 
contribute to the activation of focal adhesion signaling in astrocytes. 
 
Astrocyte morphological changes in association with neuronal activity 
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Astrocytes have highly ramified morphologies to infiltrate synaptic regions.  This 
structural characteristic enables one astrocyte contact with more than 100,000 
synapses in rodents and ~1,000,000 synapses in the human brain (Oberheim et 
al., 2006; Singh et al., 2015).  Distal processes of astrocytes are thought to be 
the main compartments that are responsible for astrocyte-neuron interaction.  
These very thin filopodia-like processes (often 50 -100 nm wide) that are actin 
rich were first visualized by Derouiche and colleagues in 2001 with 
immunolabeling of actin binding protein, ezrin (Derouiche and Frotscher, 2001).  
Like any other cellular processes that are actin rich, these fine processes can be 
rapidly extended or withdrawn from synapses in response to neuronal activity 
(Lavialle et al., 2011).  Understanding how astrocytes develop and maintain their 
dynamic morphology has been a great interest because these fine processes not 
only position themselves close to synapses but also their membranes are 
densely occupied by ion channels, neurotransmitter receptors, and transporters 
(Vernadakis, 1996; Walz, 1989).  Thus these morphological and functional 
characteristics of astrocyte membranes are essential components to investigate 
astrocytic contribution on neuronal activity and circuit behavior. 
 Initial observations of the dynamics of astrocyte processes in response to 
neuronal signaling were in cultured hippocampal astrocytes.  With brief 30 sec 
exposure to the neurotransmitter glutamate in a culture dish where primary 
neurons and astrocytes sit, researchers observed formation and extension of 
filopodia along the edge of astrocyte membrane (Cornell-Bell et al., 1990).  
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These plastic changes of astrocyte processes also exist in the intact brain.  In the 
hypothalamic supraoptic nucleus, while neurons undergo substantial remodeling 
during lactation, astrocytes also alter their morphologies to regulate glutamate 
concentration at synapses.  This striking structural remodeling is highly plastic 
(Oliet et al., 2001).  A later study, where mouse somatosensory cortex was used 
to investigate structural and functional plasticity of astrocytes upon neuronal 
activity, revealed whisker stimulation elicited increased astrocyte coverage as 
well as enhanced expression of GLT1 and GLAST (astrocyte specific glutamate 
transporters) in the cortex (Genoud et al., 2006).  An additional in vivo study in 
the mouse cerebellum corroborated the notion that astrocytes alter the extent of 
their processes in response to neuronal stimuli: motor skill learning through 
consecutive training induced the hypertrophy of astrocyte processes and again 
the change was reversed when training was terminated (Kleim et al., 2007).  
Despite increasing evidence supporting the existence of plastic changes in 
astrocyte processes in association with altered neuronal activity, we know almost 
nothing about the molecular cascades regulating the morphology of fine 
astrocyte membranes. 
 We investigated changes of astrocyte processes and their association with 
synapses at the ultrastructural level using electron microscopy.  Our 
ultrastructural analysis revealed that astrocyte processes undergo significant 
alterations in their morphological parameters by astrocyte specific depletion of 
βintegrin or in response to increased neuronal activity.  This is the first 
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experiment, to my knowledge, to show morphological plasticity in mature 
Drosophila astrocytes in response to altered neuronal activity.  By comparing 
control animals to animals expressing βintegrin RNAi in astrocytes, we found that 
percent of coverage by astrocyte processes in neuropil of Drosophila 3rd instar 
ventral nerve cord was decreased by ~20% suggesting βintegrin containing focal 
adhesion signaling regulates the extent of astrocytic processes in the neuropil 
(Fig 3.9 A, B).  It is important to note that when we visualized astrocytes with 
expression of membrane-tethered GFP under confocal light microscopy, gross 
morphology and positioning of astrocytes was unchanged (Data not shown. Data 
generated by Allie K Muthukumar).  In all likelihood, the fine processes of 
astrocytes that infiltrate deep into neuropil cannot be entirely captured by light 
microscopy due to resolution limitations.  Interestingly, when βintegrin 
knockdown animals were subjected to increased neuronal activity by PTX 
treatment, we were able to see a significant increase in the extent of astrocyte 
processes compared to mock treatment while control animals showed no 
alterations in astrocyte coverage (Fig 3.9 A, B).  These data strongly suggest that 
inhibition of focal adhesion signaling allows for more dramatic changes of 
astrocyte morphology, in other words focal adhesion signaling negatively 
regulates astrocyte coverage during elevated neuronal activity.  Furthermore, this 
morphological change in βintegrin RNAi expressing animals allows astrocytes to 
position their membrane closer to synapses thereby enhancing astrocyte 
coverage of synaptic elements (Fig 3.9C).  To elaborate, by changing the 
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distribution of astrocytic processes toward synapses, neurotransmitter 
transporters in astrocyte membranes are placed more closely to the 
neurotransmitter release sites and can more directly shape synaptic transmission.
 Also worth noting, we did not observe complete wrapping of synapses by 
astrocyte processes as reported in certain mammalian brain regions (Genoud et 
al., 2006) and this is consistent with observation from another EM study in 
Drosophila 3rd instar larvae (MacNamee et al., 2016; Stork et al., 2014).  We can 
only speculate but we do not think that this comes from differences in organisms 
because even in mammalian brain, the cortical region has less than 10 % of 
synapses ensheathed by astrocytes (Genoud et al., 2006). 
 An important consideration regarding our EM study is that within our 
sampled volumes, it is possible that the measurement comes from the astrocyte 
processes that belong to as few as one astrocyte.  Even though a previous study 
suggested it is unlikely that Drosophila astrocytes have heterogeneity in terms of 
genetic programming (Stork et al., 2014), it still remains a possibility that each 
astrocyte responds differently with their morphology to neuronal activity 
depending on their neighboring neuronal cell types and molecular environment.  
With this in mind, it is possible that we may have missed capturing heterogeneity 
in terms of morphological changes that could exist between different segments or 
different positioning within the VNC.  In the future, one could use the more high-
throughput approach of super-resolution microscopy, which can give us twice the 
resolution (~100 nm) of regular confocal microscopy, potentially resolving 
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astrocyte fine processes.  Combined with genetic tools to label astrocyte 
membrane in a clonal manner, this could allow us analyze the morphology of 
single astrocytes from different segments and positions (e.g. thoracic vs 
abdominal or dorsal vs ventral). 
 How can restricted expression of cell adhesion molecules permit structural 
plasticity in astrocytes in response to altered neuronal activity?  One possibility is 
that βintegrin depleted astrocytes can more readily expand their processes upon 
PTX treatment, perhaps due to reduced adhesiveness or they simply have more 
room to expand since they are hypotrophic compared to wild-type astrocytes in 
control conditions.  Astrocytes certainly appear capable of significant expansion 
in the Drosophila CNS in response to certain conditions.  For instance, astrocytes 
organize their spatial domains not to intrude in each other’s space and this so 
called “tiling” behavior is well conserved in Drosophila astrocytes (Stork et al., 
2014).  However, if a neighboring astrocyte is removed by genetic ablation, the 
remaining astrocytes extend their domain into the open neuropilar space.  Having 
reduced cell adhesion molecules on astrocyte membranes could also enhance 
morphological alterations upon hyperexcitability.  It is well defined that cell 
morphology is strongly dependent on adhesive properties and integrin containing 
focal adhesion complexes are the major force for the cell adhesion (Parsons et 
al., 2010).  Previous studies on how connexin 30 in astrocytes can elongate their 
processes and enhance ramification through its cell adhesion regulatory behavior 
complement this hypothesis (Pannasch et al., 2014).  Our findings certainly leave 
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many open questions.  Could this morphological change be preferential towards 
certain types of synapses (glutamatergic, GABAergic, or cholinergic to name a 
few)?  If so, are there other astrocytic molecules involved in the process other 
than focal adhesions?  This could potentially be answered by exploring some of 
the remaining hits from our screen.  Are there direct changes we could observe 
in astrocyte motilities by genetic alterations and/or neuronal activity using higher 
resolution microscopy methods?  Astrocyte processes are capable of rapid 
extension and retraction via actin cytoskeleton remodeling which can be more 
dynamic than dendritic spines (Haber, 2006).  Since focal adhesions are the 
main regulator of actin cytoskeleton, one can easily imagine how altering focal 
adhesions in astrocytes can affect motilities of their processes. 
 Finally, although we observed no significant changes in overall synapse 
number in our study by manipulation of activity or βintegrin signaling, this does 
not necessarily mean there are no alterations in composition of different types of 
synapses.  For example, there maybe increased numbers of inhibitory synapses 
and decreased excitatory synapses so that they have hypoactive network with 
βintegrin knockdown in astrocytes that leads to elevated threshold for the 
seizure-like behaviors.  Future work defining the precise synaptic changes that 
occur in response to astrocyte-specific alteration of FA signaling will be essential 
for us to answer these questions.  Additionally, changes in intrinsic properties of 
neurons can be another factor to consider in terms of synaptic activity.  
Homeostatic plasticity is a cell-autonomous mechanism in neurons to balance 
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between excitation and inhibition by scaling up or down the postsynaptic AMPA 
receptor levels (Sun and Turrigiano, 2011; Turrigiano et al., 1998).  Treatment of 
pictoroxin for 24 hr to induce chronic changes in neuronal activity leads to 
homeostatic adjustments of synaptic AMPA receptors resulting in reduced 
excitatory action (Turrigiano et al., 1998).  While 9 hr of picrotoxin treatment 
might not be long enough to induce homeostatic changes, it might be an 
interesting avenue for future studies since homeostatic plasticity in Drosophila 
CNS has not been explored.  
 
Glutamatergic signaling and EAAT1 regulation 
Glutamate is the primary excitatory neurotransmitter in the vertebrate nervous 
system. Being such an essential component of the nervous system, 
understanding development and maintenance of glutamatergic synapses and 
mechanisms underneath their signaling cascades has been one of the main 
focuses in the field of neuroscience.  On top of the intensive focus on 
understanding the physiology of glutamatergic synapses from a neuron-centric 
perspective, significant efforts have been put into studying glial regulation of 
glutamate-mediated signaling, and here astrocytes play a critical role.  Once 
glutamate is released from presynaptic neurons, it is critical that extracellular 
glutamate is properly cleared from the extracellular space to terminate activation 
of postsynaptic receptors and prevent an excitotoxic environment.  Because of 
the lack of degradative enzymes for glutamate at the synapses, transporter-
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mediated uptake is the only known mechanism of the neurotransmitter clearance.  
Among five different subtypes that are identified in mammals, EAAT1 (GLAST) 
and EAAT2 (GLT-1) have been characterized as functionally prevalent glutamate 
transporter subtypes with selective expression in astrocytes (Chaudhry et al., 
1995; Danbolt, 2001).  Along with concentrated expression pattern near 
glutamatergic synapses, direct implication of the glial glutamate transporter GLT-
1 and extracellular glutamate levels has been shown with genetic deletion of the 
transporters (Rothstein et al., 1996).  
 Drosophila also utilize glutamate as a major neurotransmitter and 
glutamatergic synapses are abundant both in CNS and PNS (Daniels et al., 
2008).  Drosophila neuromuscular junctions (NMJs) have served as an excellent 
system to study development and function of glutamatergic signaling because of 
their easy access using techniques like electrophysiology, dye labeling, and Ca2+ 
imaging.  Furthermore the fly molecular genetic toolkit empowers the system by 
allowing rapid generation of genetic mutants with high temporal and spatial 
control (Collins and DiAntonio, 2007).  
 In the Drosophila CNS, abundant expression of vesicular glutamate 
transporters (VGLUT) in neurons and enrichment of glutamate transporter 
(EAATs) in neuropil glia strongly suggest an important contribution of glia to 
regulation of glutamatergic signaling in invertebrates (Daniels et al., 2008; Stacey 
et al., 2010).  Recent studies unraveled critical functions of Drosophila glial 
glutamate transporter (EAAT1) in glutamate buffering and neuronal circuit 
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function as well as behavior (Rival et al., 2004; Stacey et al., 2010).  Drosophila 
EAAT1 is highly conserved in terms of amino acid identity compared to human 
EAAT1 and EAAT2 and it is less likely to complicate studies of EAAT1 loss of 
function since it is a sole high-affinity glutamate transporter in Drosophila 
(Besson et al., 2000).  In addition, it is selectively expressed in a subpopulation 
of CNS glial cells (Freeman et al., 2003; Soustelle et al., 2002).  While other glial 
subtypes express EAAT1 in the fly CNS, its expression in astrocytes is prominent 
(Doherty et al., 2009; Peco et al., 2016) (Fig 3.10A).  Previous studies have also 
shown that EAAT1 expression is in close proximity to VGlut synaptic punctae, 
which strongly imply potential modulation in glutamatergic neurotransmission by 
glial EAAT1 (Daniels et al., 2008; Stacey et al., 2010).  Loss-of-function mutation 
data provide direct evidence that EAAT1 acts on glutamatergic 
neurotransmission regulating the rhythmic patterning of motor neuron activity to 
control locomotor behavior (Stacey et al., 2010).  Also, inactivation of EAAT1 by 
RNA interference led to various neurological defects including oxidative stress, 
neurodegeneration, and shortened life span implying glutamate buffering by 
EAAT1 is required for maintenance of healthy brain (Rival et al., 2004).  
 We know very little about how EAATs are regulated in glia.  Fringe-
mediated neuron-glia communication has been implicated as a regulative 
mechanism of Drosophila EAAT1 expression within a glial subtype called 
longitudinal glia during development of the nervous system (Stacey et al., 2010).  
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However, how their expression level is controlled, particularly by astrocytes, in 
response to neuronal activity has not been explored much. 
  While EAAT1 protein expression in the whole brain from wild-type 
animals does not appear to be changed upon 9 hr of PTX application, there was 
about two-fold increase in EAAT1 level by knocking down either βintegrin or 
tensin in astrocytes when we compare with or without PTX treatment (Fig 3.11A, 
C).  These findings strongly suggest during network hyperexcitability, EAAT1 
expression is increased, presumably to allow for better glutamate clearance at 
synapses in RNAi groups resulting in suppression of seizure-like behavior.  
 While we did not observe any alterations in EAAT1 level in wild-type with 
increased neuronal activity, previous work in rodents showed increasing neuronal 
activity by whisker stimulation results in enhanced expression of astrocyte 
glutamate transporters (GLT-1 and GLAST) suggesting neuronal activity is linked 
to EAAT regulation (Genoud et al., 2006).  This discrepancy may be explained by 
the differences in time scale of the experimental settings.  We only waited for 9 hr 
after PTX administration before we performed quantitative western blot analysis, 
while Genoud et al. observed an increase in the transporters after 24 hr of 
whisker stimulation.  In fact, 1 hr after longer-term potentiation (LTP) stimulation 
or contextual fear conditioning does not lead to any changes in protein 
expression of GLT-1 and GLAST in rat hippocampus (Levenson et al., 2002).  
We also observed a significant down regulation of EAAT1 in astrocyte 
knockdown of focal adhesion molecules compared to wild-type.  These findings 
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are consistent with a mammalian study (Robel et al., 2015) showing astrocyte 
knockout of β1integrin leads to impaired glutamate uptake by astrocytes with 
decreased GLT-1 levels.  However, decreased level of EAAT1 by βintegrin or 
tensin knockdowns displayed normal locomotion when EAAT1 depletion in 
astrocytes by RNAi caused significant defect in crawling behavior (Fig 3.10C).  
The reason for this difference is unclear, but may result from a delayed effect on 
changes in EAAT1 levels by focal adhesion knockdowns (i.e. RNAi), which might 
enable animals bypass any developmental defects.  In fact, GLT-1 
downregulation started to appear when β1integrin knockout mice were 6 months 
old (Robel et al., 2015).  
 To further explore the functional contribution of EAAT1 to the behavioral 
phenotype in focal adhesion knockdowns, we utilized pharmacological inhibitor 
for glutamate transporter, dihydrokainate (DHK) in our PTX-induced behavioral 
assay.  We found that the suppression phenotype in animals expressing either 
βintegrin or tensin RNAi in astrocytes was significantly rescued with co-
application of DHK with PTX (Fig 3.12A).  Likewise, DHK application also 
reversed the effect of Mmp1 RNAi in the behavioral assay (Fig 3.12B).  These 
data strongly argue that the suppression of seizure-like behavior in animals with 
astrocyte focal adhesion knockdown is due, at least in part, to increased EAAT1 
expression that could relieve hyperexcitability by regulating extracellular 
glutamate concentrations.  Administration of DHK itself did not affect the 
locomotion behavior of 3rd instar larvae (Fig 3.10B).  This is not surprising 
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because studies in mouse neocortex have shown that glutamate uptake inhibition 
by pharmacological inhibitors, including the same inhibitor used in this study, 
does not affect the amplitude or decay kinetics of AMPA-mediated EPSCs in 
layer II/III pyramidal neurons (Campbell and Hablitz, 2004).  However, in the 
presence of bicuculline, another GABAA receptor blocker lowered the threshold 
for evoking seizure activity and prolonged the duration of seizure activity 
(Campbell and Hablitz, 2004).  This implies that glutamate clearance at synapses 
becomes more critical for the network excitability when a substantial number of 
neurons are activated. 
 Further work will be necessary to dissect which glial subtype contributes 
most significantly to the alteration of EAAT1 level in the larval CNS, if it is not 
solely astrocytes.  Nevertheless, our data highlight that glial EAAT1 expression 
and function is regulated by focal adhesion signaling in astrocytes during network 
hyperexcitability. 
 Currently we can only speculate why overexpression of EAAT1 in 
astrocytes shows no effect on PTX-induced locomotion defect (Fig 3.13).  It could 
reflect differences between acute versus chronic upregulation of EAAT1.  In fact, 
genetic overexpression of EAAT1 in astrocytes alone has impaired larval 
locomotion significantly, which could mean proper regulation of extracellular 
glutamate is critical for controlling motor function in vivo; ectopic expression of 
this protein over the course of development could lead to compensatory changes 
in the network; or levels of membrane exposure are regulated post-translationally 
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(Schlag et al., 1998).  To bypass developmental changes by EAAT1 
overexpression, we could utilize temperature-sensitive GAL80 molecule to 
control the timing of protein overexpression or pharmacological approach with 
antibiotics called β-lactam.  β-lactam has been shown to increase GLT1 
expression in rodents to modulate neuronal plasticity, neuroprotection and 
behavior (Bellesi et al., 2009; Omrani et al., 2009; Rothstein et al., 2005).  These 
alternative approaches would allow us to eliminate potential developmental 
compensation by chronic overexpression of EAAT1.  Lastly, our favored 
hypothesis to explain EAAT1 overexpression data is that increasing EAAT1 
without changes of astrocytic processes is not sufficient for the necessary levels 
glutamate clearance during intense neuronal activity to rescue behavioral 
defects.  In fact, recent studies have shown that increasing GLT1 density on 
astrocytes without their protrusions toward synaptic clefts made no changes on 
AMPA receptor currents (Pannasch et al., 2014).  To test whether both increased 
EAAT1 level and astrocyte coverage of the neuropil are required to suppress 
seizure-like behavior in the animals with focal adhesion knockdowns, we can 
block protein synthesis using cycloheximide during PTX feeding to see if it still 
suppresses the behavior.  In parallel, withdraw cycloheximide afterward and 
examine if the suppression of the behavior comes back.  If indeed both 
modifications in astrocytes, increased neuropil coverage and EAAT1 level are 
required to ameliorate the imbalance between excitation and inhibition, it is even 
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more plausible to think excitatory glutamatergic synapses are the most affected 
by astrocytes to suppress seizure-like behavior.  
 Going forward, significant work will be required to determine detailed 
mechanisms underlying EAAT1 regulation by astrocyte focal adhesion signaling.  
To determine whether the changes in EAAT1 protein levels are mediated by 
transcriptional or post-transcriptional modification, we could perform quantitative 
PCR to compare EAAT1 mRNA levels between genotypes (wilde-type vs 
astrocyte focal adhesion RNAi) and treatments (control food vs PTX containing 
food).  Transcriptional regulators downstream of βintegrin could be involved in 
regulation of EAAT1 expression.  The link between astrocyte glutamate 
transporter expression and the nuclear transcription factor nuclear factor-κB (NF-
κB) has been reported previously(Lee et al., 2008; Sitcheran et al., 2005) and 
later it was defined that NF-κB binds directly to GLT1 promoter regions to 
regulate the transcript, which requires neuronal signaling (Ghosh et al., 2011).  
Other downstream effectors of focal adhesion signaling and their potential roles 
are discussed in Appendix1. 
 In addition, there are many levels of crosstalk between mentioned 
intracellular signaling pathways (Ben Haim et al., 2015) which means we need to 
develop more careful and elegant approaches on studying regulatory 
mechanisms of EAAT1 for future studies. 
Beyond changes in protein expression, another mechanism to modulate 
transporter function is alteration of membrane surface exposure dynamics (e.g. 
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insertion, surface diffusion and membrane trafficking).  Neuronal glutamate 
transporters have revealed that trafficking of the transporters from cytosol to the 
membrane is important mechanism by which synapses maintain appropriate 
synaptic strength during LTP and fear conditioning (Levenson et al., 2002).  A 
recent study using a single nanoparticle (quantum dot,QD) tracking technique 
found that surface diffusion of astrocyte glutamate transporter, GLT1 was a key 
mechanism to maintain synaptic glutamate homeostasis in vitro (Murphy-Royal et 
al., 2015).  Thus, to further improve our knowledge of the transporter contribution 
on regulating glutamate concentration at synapses, understanding their 
membrane dynamics is a necessary avenue. 
 
Concluding remarks 
The balance between excitatory/inhibitory inputs in the central nervous system 
has to be in a certain range to maintain normal and healthy brain function.  This 
balance is compromised in many neurological disorders, in which neurons 
experience chronically elevated activity (Heinemann, 2004; Rubenstein, 2010; 
Yizhar et al., 2011).   
 Astrocytes have tight coupling with neuronal synapses and their membranes are 
equipped with molecules to regulate network activity.  My thesis work has 
contributed to understanding of how astrocytes regulate neuronal activity to 
eventually adjust excitatory/inhibitory balance in the brain network.  My work 
demonstrated that focal adhesion signaling in astrocytes is a critical pathway for 
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their association with synapses and expression of glutamate transporters in 
response to changing network environment.  Especially the alterations of 
glutamate transporters can result in direct modulation of excitatory synaptic 
signals, which ultimately influence the balance between excitation/inhibition.  
Additionally, our comprehensive screen suggests a deeper analysis of astrocyte 
molecules to understand how astrocytes modulate CNS excitability and signaling. 
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Appendix 
Potential downstream targets of astrocyte focal adhesion 
signaling 
Activation of the c-jun N-terminal kinase (JNK) cascade upon integrin activation 
has been well documented (Jeffrey et al., 2007).  Thus we expressed two 
different RNAis for JNK in astrocytes to test if PTX-induced seizure behavior is 
modified.  While only one of the RNAi lines showed a significant suppression of 
the behavior, both RNAi lines resulted in a severe defect in basal locomotion 
when they were expressed in astrocytes (Fig A.1A).  Given that JNK/c-Jun 
signaling pathway regulates such a wide range of cellular processes; it is not 
surprising that JNK signaling is required for normal locomotion (Figure A.1A).  
There is a close association between activation of focal adhesion signaling and 
ROCK (Rho-associated, coiled-coil containing protein kinase) signaling (Goetsch 
et al., 2014; Wozniak et al., 2004).  In addition, ROCK regulation of astrocyte 
morphology and EAAT expression has been documented in vitro cell culture 
system (Lau et al., 2011).  However, when we altered ROCK expression or 
activity with genetic and pharmacological approaches, no changes in seizure-like 
behavior by PTX treatment was observed (Fig A1B, C, D). 
Lastly, our preliminary data suggested a possible contribution of ERK to 
the suppression of PTX-induced seizure (Fig A1E).  While positive regulation of 
ERK activity by focal adhesion signaling has been widely observed (Lambert et 
al., 2012), the opposite mode of action has also been suggested in more non-
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canonical signaling between ERK and focal adhesion signaling in Drosophila 
neuromuscular junction (Tsai et al., 2008).  In our hands, both ERK 
overexpression and ERK RNAi resulted in suppression of the seizure behavior 
(though we note overexpression had much greater degree of suppression than 
RNAi) (Fig A.1E).  Future work will be required to clarify the nature of FA/ERK 
signaling interactions in E/I balance and hyperexcitability in the Drosophila 
nervous system, but the strong phenotypes observed with both manipulations 
argue for an important role for ERK in this context.   
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Figure A.1: Tests of potential downstream molecules of astrocyte focal 
adhesions  
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A, Depletion of JNK in astrocytes by RNAi impaired basal locomotion of larvae 
compared to control genotype but showed no changes in PTX induced seizure.   
Error bars represent SEM.  **P<0.005, ****P<0.0001; two-way ANOVA and 
Dunnett’s multiple comparisons test.  B, Genetic alteration of ROK either by RNAi 
or overexpression of constitutively active ROK in astrocytes made no difference 
in both basal locomotion and PTX induced seizure compared to wilde-type.  Error 
bars represent SEM.  Two-way ANOVA and Dunnett’s multiple comparisons test.  
C, Pharmacological inhibition of ROCK with Fasudil during PTX feeding showed 
no changes in locomotion defect suppression.  Two-way ANOVA and Dunnett’s 
multiple comparisons test.  D, 6 hr of pretreatment of Fasudil does not affect PTX 
induced behavior.  Error bars represent SEM.  Two-way ANOVA and Dunnett’s 
multiple comparisons test.  E, Either overexpression or knockdown of ERK in 
astrocytes significantly suppresses seizure behavior by PTX while 
overexpression of constitutively active form of ERK had no effect.  Error bars 
represent SEM.  *P<0.005, ****P<0.0001; two-way ANOVA and Dunnett’s 
multiple comparisons test. 
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Potential applications for FA signaling in disease 
Molecular mechanisms by which one could alter E/I balance and hyperexcitability 
of high interest.  Here we identified astrocyte focal adhesions through their 
regulation of EAAT as a new potential therapeutic interventions.  Neurological 
disorders like Fragile X Syndrome (FXS) and seizure that present with 
phenotypes including E/I imbalance and excitotoxicity might be excellent targets.  
Recent studies on GLT1 and Fragile X Syndrome (Higashimori et al., 2016) have 
provided a strong evidence that dysregulation of astrocyte specific glutamate 
transporter, GLT1 is underlying pathophysiology in mouse model of FXS.  To 
explore this potential link to the pathology of FXS, we utilized Drosophila FXS 
model with loss-of-function mutations in the Drosophila fragile X-related 1(dfmr1) 
that shows larval crawling defect (Siller and Broadie, 2011; Xu et al., 2004)(Fig 
A.2C, D).  Interestingly, we observed the same phenomenon as in the mouse 
model of FXS where glial EAAT expression decreases dramatically in the 
disease state (Fig A.2A, B)(Higashimori et al., 2016).  We then wondered if 
alterations of focal adhesions in astrocytes would rescue any of this 
pathophysiology.  Surprisingly, when we deplete astrocyte βintegrin in the dfmr1 
mutant background (fmr150M), we were able to see a significant rescue of the 
locomotion defect compared to the driver control (alrmGAL4; fmr150M)(Fig A.2G, 
H).  However, in our attempt to test if the underlying mechanism for the 
behavioral rescue is alteration of EAAT1 levels, we observed no changes of 
EAAT1 in our driver control nor in βintegrin RNAi in the mutant background in 
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comparison to wild-type (Fig A.2E, F).  While this might suggest no correlation 
between the behavioral rescue by βintegrin knockdown and EAAT1 levels, one 
needs to proceed in the interpretation with caution: I found the alrm-GAL4 driver 
itself had an effect on EAAT1 level in the mutant background, which complicates 
the matter. 
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Figure A.2: Potential application for a disease (Fragile X syndrome fly 
model) 
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A, Western blot samples were prepared from 3rd instar larval CNS from W1118 and 
Fmr150M .  Blots were probed with anti-EAAT1 antibody.  B, Quantification of 
EAAT1 levels from Western blot analysis shown in A (n = 5 experiments).  Error 
bars represent SEM.  **P<0.005; Unpaired t test.  C, Raw traces of 3rd instar 
larval locomotion in W1118 and Fmr150M.  D, Quantitative of the larval locomotion 
shown in C shows significant impairment of the locomotion speed in Fmr150M 
compared to W1118.  Error bars represent SEM.  ****P<0.0001; Unpaired t test.  
E, Western blot samples were prepared from 3rd instar larval CNS from 
alrmGAL4, alrmGAL4; Fmr150M, and alrmGAL4/UAS-βintegrin; Fmr150M.  F, 
Quantification of EAAT1 levels from Western blot analysis shown in E (n = 4 
experiments).  Error bars represent SEM.  Two-way ANOVA and Dunnett’s 
multiple comparisons test.  G, Raw traces of 3rd instar larval locomotion in 
alrmGAL4, alrmGAL4; Fmr150M, and alrmGAL4/UAS-βintegrin; Fmr150M.  H, 
Quantitative of the larval locomotion shown in G shows a significant rescue of the 
behavioral defect in alrmGAL4; Fmr150M compared to alrmGAL4/UAS-βintegrin; 
Fmr150M.  Error bars represent SEM.  **P<0.05; two-way ANOVA and Dunnett’s 
multiple comparisons test. 
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Table 2.1: List of genes that scored as suppressors in the screen 
 
 
Table S1. List of genes that scored as suppressors at the screen
Gene symbol CG number VDRC ID Library off-target Number of files 
Ten-a CG42338 105037 KK 0 23
by CG9379 22823 GD 0 24
CG17839 CG17839 100149 KK 1 23
drl CG17348 100039 KK 1 28
14-3-3epsilon CG31196 108129 KK 0 17
CG17124 CG17124 19078 GD 1 25
Tsp47F CG9033 44288 GD 0 30
Klp31E CG5300 34983 GD 0 25
Lmpt CG42679 42892 GD 0 25
Tsp42Eq CG12832 30329 GD 2 19
P5cr CG6009 46892 GD 0 24
plexB CG17245 27220 GD 0 10
Hem CG5837 103380 KK 0 26
CG32792 CG32792 47047 GD 0 22
CG1801 CG1801 8655 GD 0 26
CG9864 CG9864 103970 KK 1 29
tsl CG6705 14429 GD 0 19
CG33253 CG33253 6178 GD 1 32
a CG6741 16826 GD 410 26
in CG16993 103407 KK 0 32
Smvt CG2191 102662 KK 0 24
SerT CG4545 11346 GD 0 21
CG2616 CG2616 102630 KK 0 20
CG4797 CG4797 10598 GD 0 26
NepYr CG5811 103973 KK 0 19
pros CG17228 101477 KK 0 21
klg CG6669 102502 KK 0 18
fry CG32045 40309 GD 633 14
tomboy40 CG8330 105557 KK 0 22
E23 CG3327 105055 KK 1 26
CG8116 CG8116 39218 NA NA 17
CG12818 CG12818 31898 GD 0 16
scramb2 CG1893 104647 KK 1 29
ninaC CG5125 110702 KK 1 17
prc CG5700 100357 KK 1 13
GluRIIE CG31201 49547 GD 0 29
Tbh CG1543 51667 GD 0 43
PGRP-LD CG33717 5038 GD 1 37
Zip3 CG6898 37358 GD 2 39
kek5 CG12199 47768 GD 5 35
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fdl CG8824 4637 GD 0 34
babo CG8224 3825 GD 0 21
Nplp4 CG15361 104662 KK 0 22
Pdfr CG13758 106381 KK 0 13
Snmp1 CG7000 104210 KK 0 19
mgl CG42611 103661 KK 0 13
mthl8 CG32475 100246 KK 0 17
ppk25 CG33349 101808 KK 0 14
PGRP-SC2 CG14745 104578 KK 0 28
brp CG42344 104630 KK 0 12
CG4465 CG4465 100202 KK 0 15
Ir31a CG31718 100345 KK 0 10
trk CG5619 51240 GD 0 10
Sld5 CG14549 43588 GD 0 12
CG9095 CG9095 23158 GD 2 21
tipE CG1232 4482 GD 1 26
HLH106 CG8522 37640 GD 0 25
SsRbeta CG5474 12101 GD 0 17
phyl CG10108 35469 GD 0 29
sdk CG5227 9437 GD 0 21
bcd CG1034 48966 GD 0 20
trn CG11280 107883 KK 0 34
CG31103 CG31103 2657 GD 0 12
Nup358 CG11856 38583 GD 3 12
kek2 CG4977 42450 GD 1 19
CG13743 CG13743 40974 GD 540 26
CG12341 CG12341 7391 GD 0 23
CG42514 CG42514 45643 GD 0 10
l(2)01289 CG9432 107350 KK 1 24
chas CG32556 109841 KK 1 23
CG14299 CG14299 110420 KK 0 16
Drak CG32666 107263 KK 1 22
CG10486 CG10486 107903 KK 0 17
Ir67c CG32058 107921 KK 0 20
ppk21 CG12048 107892 KK 0 15
Tpc2 CG2857 107215 KK 0 20
pst CG8588 107243 KK 0 10
Gp150 CG5820 100134 KK 1 11
cos CG1708 108914 KK 0 19
KCNQ CG33135 106655 KK 0 18
CG1703 CG1703 105998 KK 0 21
Snap24 CG9474 108209 KK 0 33
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bou CG14430 107102 KK 0 22
Ptp99A CG11516 27207 GD 0 20
CG5888 CG5888 12413 GD 0 17
Gbp CG15917 108755 KK 0 27
lox2 CG4402 108217 KK 0 21
btl CG32134 110277 KK 0 16
mfas CG3359 103621 KK 1 25
CG14238 CG14238 2673 GD 0 26
gcl CG8411 28897 GD 1 17
rab3-GAP CG7061 106905 KK 0 11
Pdk1 CG1210 109812 KK 0 13
shf CG3135 14803 GD 11 16
Rala CG2849 105296 KK 0 12
CG13278 CG13278 109927 KK 0 15
CG8142 CG8142 108452 KK 1 15
jagn CG10978 108991 KK 0 11
boss CG8285 4365 GD 0 11
CG9903 CG9903 42689 GD 0 28
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Table S2. List of genes that scored as enahncers at the screen
Gene symbol CG number VDRC ID Library off-target Number of files 
alphaPS5 CG5372 100120 KK 0 27
Ipp CG12843 101044 KK 0 15
CSN7 CG2038 40690 GD 0 28
Eaat1 CG3747 109401 KK 0 18
ATPsyn-Cf6 CG4412 107826 KK 0 15
Pkc98E CG31743 105821 KK 0 16
CG31743 CG12484 104814 KK 0 12
CG12484 CG9012 103383 KK 0 16
Ir10a CG34143 100181 KK 0 22
slo CG30265 106618 KK 1 14
CG30265 CG10693 104421 KK 0 14
CG33270 CG33270 109109 KK 4 19
spin CG8428 105462 KK 0 15
CG6845 CG6845 107719 KK 0 10
Gprk2 CG17998 101463 KK 0 11
nAcRbeta-21C CG11822 42742 GD 0 11
ATP7 CG1886 108159 KK 0 11
TBPH CG10327 104401 KK 0 17
Ccn CG32183 101518 KK 0 12
betaTub60D CG3401 102052 KK 0 12
Dyb CG8529 104485 KK 1 12
RYamide CG40733 109267 KK 0 12
kz CG3228 104253 KK 0 19
Nf-YA CG3891 106132 KK 0 19
Tip60 CG6121 110617 KK 0 19
CCHa1 CG14358 104974 KK 2 19
spen CG18497 108828 KK 2 19
spz6 CG9196 100897 KK 0 13
shakB CG34358 24578 GD 0 13
Gdi CG4422 108693 KK 1 20
Vha13 CG6213 106536 KK 0 14
CaMKII CG18069 100265 KK 0 22
Takr99D CG7887 43329 GD 0 15
Cap CG9802 101501 KK 2 15
Mdh1 CG5362 110604 KK 0 15
Mcm2 CG7538 103619 KK 2 15
rdo CG15151 107213 KK 5 15
nrm CG43079 104295 KK 0 23
Girdin CG12734 103615 KK 0 23
Ccn CG32183 101520 KK 1 16
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gfA CG32538 100756 KK 0 16
CG8468 CG8468 6452 GD 0 24
sog CG9224 105853 KK 3 16
T48 CG5507 100334 KK 0 32
CG5398 CG5398 109717 KK 0 16
CG14646 CG14646 103770 KK 0 25
CG11147 CG11147 101601 KK 0 17
mam CG8118 102091 KK 0 17
nimC4 CG16876 101915 KK 0 17
CG8908 CG8908 100472 KK 1 17
CG9104 CG9104 110579 KK 0 17
CG8925 CG8925 101128 KK 0 17
Lac CG12369 107450 KK 0 26
jub CG11063 101993 KK 0 18
CG16718 CG16718 108953 KK 0 27
Synd CG33094 104580 KK 0 19
pnr CG3978 101522 KK 0 19
Ir7b CG15326 100498 KK 1 19
ppk6 CG11209 101091 KK 1 19
CG34120 CG34120 101700 KK 0 19
Tapdelta CG9035 8759 GD 0 10
Mpcp CG4994 101316 KK 1 10
Osi4 CG10303 102619 KK 0 10
Vha55 CG17369 46554 GD 1 10
VhaM9.7-a CG1268 104315 KK 0 10
dome CG14226 36355 GD 0 10
kon CG10275 106680 KK 1 10
Snmp2 CG7422 101136 KK 0 20
CG8026 CG8026 105681 KK 0 10
Bap CG12532 7721 GD 0 10
qtc CG14039 17349 GD 13 10
vlc CG8390 46230 GD 0 10
CG33298 CG33298 42776 GD 2 10
Nup44A CG8722 106489 KK 2 10
CG1090 CG1090 26783 GD 0 10
AdoR CG9753 1385 GD 0 10
Npc1b CG12092 108054 KK 0 10
Osi10 CG15593 105915 KK 0 10
Atg18 CG7986 105366 KK 0 10
Pvf1 CG7103 102699 KK 0 10
endos CG6513 106825 KK 0 10
CG30345 CG30345 103652 KK 0 10
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NtR CG6698 108234 KK 0 10
Roc1a CG16982 106315 KK 0 10
Caps CG33653 110055 KK 0 31
Toll-7 CG8595 39176 GD 2 21
cm CG3035 110746 KK 0 21
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Figure 3.3B
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-talin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
0.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-talin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-FAK RNAi ****
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-talin RNAi *
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-talin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
1.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-talin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-FAK RNAi ****
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-talin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
Figure 3.3C
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi; UAS-mCD8GFP ns
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi; UAS-tensin RNAi ns
alrmGAL4>UAS-βintegrin RNAi; UAS-mCD8GFP vs. alrmGAL4>UAS-βintegrin RNAi; UAS-tensin RNAi ns
1.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi; UAS-mCD8GFP **
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi; UAS-tensin RNAi **
alrmGAL4>UAS-βintegrin RNAi; UAS-mCD8GFP vs. alrmGAL4>UAS-βintegrin RNAi; UAS-tensin RNAi ns
Figure 3.4B
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX
W1118 vs. UAS-tensin RNAi ns
W1118 vs. UAS-βintegrin RNAi ns
W1118 vs. UAS-talin RNAi ns
W1118 vs. UAS-FAK RNAi ns
UAS-tensin RNAi vs. UAS-βintegrin RNAi ns
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UAS-tensin RNAi vs. UAS-talin RNAi ns
UAS-tensin RNAi vs. UAS-FAK RNAi ns
UAS-βintegrin RNAi vs. UAS-talin RNAi ns
UAS-βintegrin RNAi vs. UAS-FAK RNAi ns
UAS-talin RNAi vs. UAS-FAK RNAi ns
1.5 mg/ml PTX
W1118 vs. UAS-tensin RNAi ns
W1118 vs. UAS-βintegrin RNAi ns
W1118 vs. UAS-talin RNAi ns
W1118 vs. UAS-FAK RNAi ns
UAS-tensin RNAi vs. UAS-βintegrin RNAi ns
UAS-tensin RNAi vs. UAS-talin RNAi ns
UAS-tensin RNAi vs. UAS-FAK RNAi ns
UAS-βintegrin RNAi vs. UAS-talin RNAi ns
UAS-βintegrin RNAi vs. UAS-FAK RNAi ns
UAS-talin RNAi vs. UAS-FAK RNAi ns
Figure 3.4C
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-talin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
1.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-talin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-FAK RNAi ****
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-tensin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-talin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
alrmGAL4>UAS-talin RNAi vs. alrmGAL4>UAS-FAK RNAi ns
Figure 3.5
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX:W1118 vs. 0.0 mg/ml PTX:by33c ****
0.0 mg/ml PTX:W1118 vs. 1.5 mg/ml PTX:W1118 ****
0.0 mg/ml PTX:W1118 vs. 1.5 mg/ml PTX:by33c ****
0.0 mg/ml PTX:by33c vs. 1.5 mg/ml PTX:W1118 ****
0.0 mg/ml PTX:by33c vs. 1.5 mg/ml PTX:by33c ****
1.5 mg/ml PTX:W1118 vs. 1.5 mg/ml PTX:by33c ****
Figure 3.6B
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX:alrmGal4/+ vs. 0.0 mg/ml PTX:alrmGal4/UAS-Mmp1 RNAi ns
0.0 mg/ml PTX:alrmGal4/+ vs. 1.5 mg/ml PTX:alrmGal4/+ ****
0.0 mg/ml PTX:alrmGal4/+ vs. 1.5 mg/ml PTX:alrmGal4/UAS-Mmp1 RNAi ****
0.0 mg/ml PTX:alrmGal4/UAS-Mmp1 RNAi vs. 1.5 mg/ml PTX:alrmGal4/+ ****
0.0 mg/ml PTX:alrmGal4/UAS-Mmp1 RNAi vs. 1.5 mg/ml PTX:alrmGal4/UAS-Mmp1 RNAi ****
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1.5 mg/ml PTX:alrmGal4/+ vs. 1.5 mg/ml PTX:alrmGal4/UAS-Mmp1 RNAi ****
Figure 3.6C
Test used two-way ANOVA; Dunnett’s multiple comparisons
Post hoc test Summary
1.5 mg/ml PTX vs. W1118 acetone ****
1.5 mg/ml PTX vs. W1118 50µM inhibitor ****
1.5 mg/ml PTX vs. 1.5 mg/ml PTX + 50µM inhibitor *
Figure 3.6C
Test used two-way ANOVA; Dunnett’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX:elavGAL4 vs. 0.0 mg/ml PTX:elavGAL4>UAS-Mmp1 RNAi ns
0.0 mg/ml PTX:elavGAL4 vs. 1.5 mg/ml PTX:elavGAL4 ****
0.0 mg/ml PTX:elavGAL4 vs. 1.5 mg/ml PTX:elavGAL4>UAS-Mmp1 RNAi ****
0.0 mg/ml PTX:elavGAL4>UAS-Mmp1 RNAi vs. 1.5 mg/ml PTX:elavGAL4 ****
0.0 mg/ml PTX:elavGAL4>UAS-Mmp1 RNAi vs. 1.5 mg/ml PTX:elavGAL4>UAS-Mmp1 RNAi ****
1.5 mg/ml PTX:elavGAL4 vs. 1.5 mg/ml PTX:elavGAL4>UAS-Mmp1 RNAi ns
Figure 3.8A
Test used two-way ANOVA; Bonferroni’s multiple comparisons
Post hoc test Summary
alrmGAL4 - alrmGAL4>UAS-βintegrin RNAi
0.0 mg/ml PTX ns
50 mm inhibitor ns
1.5 mg/ml PTX *
1.5 mg/ml PTX + 50 mM inhibitor ns
Figure 3.8B
Test used two-way ANOVA; Dunnett’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-Mmp1 ns
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi; UAS-Mmp1 ns
1.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-Mmp1 ns
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi; UAS-Mmp1 ****
Figure 3.8C
Test used two-way ANOVA; Bonferroni’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-mCD8GFP; UAS-talin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-Mmp1; UAS-talin RNAi ns
alrmGAL4>UAS-mCD8GFP; UAS-talin RNAi vs. alrmGAL4>UAS-Mmp1; UAS-talin RNAi ns
1.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-mCD8GFP; UAS-talin RNAi *
alrmGAL4 vs. alrmGAL4>UAS-Mmp1; UAS-talin RNAi ns
alrmGAL4>UAS-mCD8GFP; UAS-talin RNAi vs. alrmGAL4>UAS-Mmp1; UAS-talin RNAi *
Figure 3.10D
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX:alrmGAL4 vs. 0.0 mg/ml PTX:alrmGAL4>UAS-Eaat1 *
0.0 mg/ml PTX:alrmGAL4 vs. 1.5 mg/ml PTX :alrmGAL4 ****
0.0 mg/ml PTX:alrmGAL4 vs. 1.5 mg/ml PTX :alrmGAL4>UAS-Eaat1 ****
0.0 mg/ml PTX:alrmGAL4>UAS-Eaat1 vs. 1.5 mg/ml PTX :alrmGAL4 ****
0.0 mg/ml PTX:alrmGAL4>UAS-Eaat1 vs. 1.5 mg/ml PTX :alrmGAL4>UAS-Eaat1 ****
1.5 mg/ml PTX :alrmGAL4 vs. 1.5 mg/ml PTX :alrmGAL4>UAS-Eaat1 ns
Figure 3.12A
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
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0.0 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-tensin RNAi ns
1.5 mg/ml PTX
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ****
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ****
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-tensin RNAi ns
1.5 mg/ml PTX + 500 mM DHK
alrmGAL4 vs. alrmGAL4>UAS-βintegrin RNAi ns
alrmGAL4 vs. alrmGAL4>UAS-tensin RNAi ns
alrmGAL4>UAS-βintegrin RNAi vs. alrmGAL4>UAS-tensin RNAi ns
Figure 3.12A
Test used two-way ANOVA; Bonferroni’s multiple comparisons
Post hoc test Summary
alrmGAL4 - alrmGAL4>UAS-Mmp1 RNAi
0.0 mg/ml PTX ns
1.5 mg/ml PTX *
1.5 mg/ml PTX + 50 mM DHK ns
Figure 3.12A
Test used two-way ANOVA; Tukey’s multiple comparisons
Post hoc test Summary
0.0 mg/ml PTX:alrmGAL4 vs. 0.0 mg/ml PTX:alrmGAL4>UAS-Eaat1 *
0.0 mg/ml PTX:alrmGAL4 vs. 1.5 mg/ml PTX :alrmGAL4 ****
0.0 mg/ml PTX:alrmGAL4 vs. 1.5 mg/ml PTX :alrmGAL4>UAS-Eaat1 ****
0.0 mg/ml PTX:alrmGAL4>UAS-Eaat1 vs. 1.5 mg/ml PTX :alrmGAL4 ****
0.0 mg/ml PTX:alrmGAL4>UAS-Eaat1 vs. 1.5 mg/ml PTX :alrmGAL4>UAS-Eaat1 ****
1.5 mg/ml PTX :alrmGAL4 vs. 1.5 mg/ml PTX :alrmGAL4>UAS-Eaat1 ns
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